EP2647426A1 - Replication of distributed nucleic acid molecules with preservation of their relative distribution through hybridization-based binding - Google Patents
Replication of distributed nucleic acid molecules with preservation of their relative distribution through hybridization-based binding Download PDFInfo
- Publication number
- EP2647426A1 EP2647426A1 EP12163055.2A EP12163055A EP2647426A1 EP 2647426 A1 EP2647426 A1 EP 2647426A1 EP 12163055 A EP12163055 A EP 12163055A EP 2647426 A1 EP2647426 A1 EP 2647426A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- nucleic acid
- acid molecules
- sample
- hybridization
- target surface
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 203
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 200
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 200
- 238000009396 hybridization Methods 0.000 title claims description 146
- 230000010076 replication Effects 0.000 title claims description 34
- 238000004321 preservation Methods 0.000 title description 3
- 238000000034 method Methods 0.000 claims abstract description 47
- 108091034117 Oligonucleotide Proteins 0.000 claims description 96
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims description 80
- 238000012163 sequencing technique Methods 0.000 claims description 61
- 230000000295 complement effect Effects 0.000 claims description 32
- 238000004458 analytical method Methods 0.000 claims description 22
- 230000003321 amplification Effects 0.000 claims description 19
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 19
- 239000003795 chemical substances by application Substances 0.000 claims description 15
- 238000003776 cleavage reaction Methods 0.000 claims description 14
- 230000007017 scission Effects 0.000 claims description 14
- 230000003247 decreasing effect Effects 0.000 claims description 12
- 238000006243 chemical reaction Methods 0.000 claims description 11
- 102000004190 Enzymes Human genes 0.000 claims description 10
- 108090000790 Enzymes Proteins 0.000 claims description 10
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 9
- 230000015572 biosynthetic process Effects 0.000 claims description 9
- 238000009792 diffusion process Methods 0.000 claims description 9
- 238000002474 experimental method Methods 0.000 claims description 7
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 claims description 6
- 238000006911 enzymatic reaction Methods 0.000 claims description 5
- 238000007850 in situ PCR Methods 0.000 claims description 4
- 238000003499 nucleic acid array Methods 0.000 claims description 4
- 238000005096 rolling process Methods 0.000 claims description 4
- 208000035657 Abasia Diseases 0.000 claims description 3
- 230000008859 change Effects 0.000 claims description 3
- 239000003153 chemical reaction reagent Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 claims description 3
- 238000012408 PCR amplification Methods 0.000 claims description 2
- 238000002844 melting Methods 0.000 claims description 2
- 230000008018 melting Effects 0.000 claims description 2
- 238000003498 protein array Methods 0.000 claims description 2
- FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 claims 3
- GNFTZDOKVXKIBK-UHFFFAOYSA-N 3-(2-methoxyethoxy)benzohydrazide Chemical compound COCCOC1=CC=CC(C(=O)NN)=C1 GNFTZDOKVXKIBK-UHFFFAOYSA-N 0.000 claims 1
- 239000000523 sample Substances 0.000 description 168
- 239000000243 solution Substances 0.000 description 43
- 239000011324 bead Substances 0.000 description 16
- 239000007787 solid Substances 0.000 description 14
- 239000002773 nucleotide Substances 0.000 description 12
- 125000003729 nucleotide group Chemical group 0.000 description 12
- 239000000203 mixture Substances 0.000 description 8
- 108091026890 Coding region Proteins 0.000 description 7
- 239000000872 buffer Substances 0.000 description 6
- 238000011534 incubation Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 238000007901 in situ hybridization Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 239000004593 Epoxy Substances 0.000 description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- 108700026244 Open Reading Frames Proteins 0.000 description 3
- 238000000137 annealing Methods 0.000 description 3
- 238000005286 illumination Methods 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000011534 wash buffer Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 238000003491 array Methods 0.000 description 2
- 230000031018 biological processes and functions Effects 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 238000011066 ex-situ storage Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 230000004807 localization Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 125000006850 spacer group Chemical group 0.000 description 2
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002966 oligonucleotide array Methods 0.000 description 1
- 238000002515 oligonucleotide synthesis Methods 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 238000012176 true single molecule sequencing Methods 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1093—General methods of preparing gene libraries, not provided for in other subgroups
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/0046—Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6841—In situ hybridisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
- C12Q1/6874—Methods for sequencing involving nucleic acid arrays, e.g. sequencing by hybridisation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00351—Means for dispensing and evacuation of reagents
- B01J2219/00382—Stamping
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00497—Features relating to the solid phase supports
- B01J2219/00527—Sheets
- B01J2219/00533—Sheets essentially rectangular
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00585—Parallel processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00596—Solid-phase processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/00608—DNA chips
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/00623—Immobilisation or binding
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00659—Two-dimensional arrays
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00718—Type of compounds synthesised
- B01J2219/0072—Organic compounds
- B01J2219/00722—Nucleotides
Definitions
- a replica of distributed nucleic acid molecules is created by hybridization of nucleic acids located on a surface or within a layer of a sample to a target surface by hybridization to complementary sequences.
- Target surface may be for example covered with oligonucleotides, complementary to the nucleic acids on the sample or hybridization may occur through adapter oligonucleotides complementary both to the oligos on the target surface and to the nucleic acid molecules on the sample.
- Biological processes are spatially organized. They rely upon the interplay of many different components forming an intricate structure of cells, tissues and organisms. Molecules participating in these processes have a certain spatial distribution. Understanding the biological processes is critically dependent on a detailed knowledge of this distribution.
- tissue sections Objects with two-dimensional distribution of nucleic acid molecules, for example tissue sections, are widely studied. There exist methods for nucleic acid analysis in tissue sections, for example in situ hybridization or in situ PCR. However, not all molecular biology methods are applicable when working with tissue sections.
- tissue sections are convenient objects to study distribution of molecules.
- Several sequential sections restore a 3D spatial location of molecules.
- many molecular biology methods, for example sequencing cannot be performed directly in tissue sections. It would be advantageous to be able to transfer molecules from the tissue section to another surface or into solution, where appropriate methods of analysis could be performed. However, such transfer raises questions of keeping information about initial distribution of the nucleic acid molecules.
- nucleic acid array features are first amplified on the array, then the array with amplified features is brought into tight contact with transfer support, to which parts of amplified molecules are transferred and get covalently attached ( U.S. Patent 7,785,790 ).
- nanostamping approach nucleic acid molecules hybridised to sample surface are brought into direct contact with capturing groups on the target surface. Chemical binding with the target surface is stronger than hybridization and after separating surfaces, nucleic acid molecules remain on the target surface ( U.S. Patent 7,862,849 ).
- the general principle of replication is bringing into contact a surface with 2D distributed nucleic acid molecules with a target surface, to which they are transferred by diffusion or direct contact. So far nucleic acid molecules have been transferred to surfaces were they were captured either physically (stuck in gel) or by chemical bonds (covalent, ion exchange, affinity) involving certain reactive groups on the nucleic acid molecules and on the target surface, but not involving the nucleotide sequence of the molecules.
- Objective of the present invention is to provide a method capable of preserving the information about spatial distribution of nucleic acid molecules transferred from a surface to another surface.
- the present invention is directed to methods for preserving information about original spatial distribution of nucleic acid molecules transferred from a surface to another surface or into solution.
- Hybridization as a way to capture nucleic acid molecules makes the replication highly selective, since only nucleic acid molecules having complementary sequences will be hold on the target surface. Besides, hybridization is a controllable process and allows regulation of the time of replication and, consequently, the number of transferred nucleic acid molecules.
- the method does not require direct contact of 2D distributed nucleic acid molecules to binding sites on the target surface. This means that (i) the transfer may be performed between large solid surfaces, which can't form uniform tight contact and (ii) the method may be applied to transfer nucleic acid molecules from 3D samples to the target surface.
- replica refers to a copy of the distribution of nucleic acids with preservation of their original distribution to a target surface by hybridization.
- the target surface with the transferred nucleic acids held by hybridization with preservation of their original distribution is the created replica.
- replica is obtaining on a target surface the relative distribution of nucleic acid molecules or molecular complexes containing nucleic acid molecules resembling the original distribution.
- the replication method according to the invention comprises the following steps:
- the nucleic acid molecules can be either located on the surface of the sample or within a layer of the sample.
- the nucleic acid molecules located on a surface or within the layer are distributed on a nucleic acid array or protein array, and wherein said nucleic acid molecules distributed within a layer are distributed in a gel layer, in tissue section, in cell or tissue array or in block of tissue.
- the nucleic acids can be contained in a gel and can be mobilized out of the gel to the surface of the gel.
- the nucleic acids can be provided on a glass slide.
- the sample with nucleic acid molecules also comprises nucleic acids that are hybridized to the nucleic acids on the sample. This means that nucleic acids could be distributed on the sample and to this nucleic acids further nucleic acids are hybridized.
- nucleic acids could be distributed on the sample and to this nucleic acids further nucleic acids are hybridized.
- providing a sample with nucleic acids molecules located either on a surface or within a layer also includes hybridization products of nucleic acids. Consequently, the term nucleic acids also comprise hybridization products of nucleic acids.
- the target surface comprises a plurality of at least one type of oligonucleotides attached to the target surface.
- the target surface can be of any texture.
- the target surface should be covered with oligonucleotides, at least in the area to which the transfer is performed. Transferred nucleic acid molecules hybridize preferably directly to the oligonucleotides immobilized on the target surface.
- the nucleic acids may be either attached or not attached to the sample. If the nucleic acids are not attached to the sample it is preferred to apply conditions to minimize the shift of nucleic acid molecules from their respective original positions. Such conditions could be the decrease of temperature. Preferably, the temperature is decreased below 24°C, preferably 20°C, more preferably 16°C, preferably 12°C, even more preferred 8°C, and more preferred 4°C.
- nucleic acids are attached to the sample it may be advisable to apply conditions, wherein gradual release of the nucleic acids in the sample occurs.
- the nucleic acids may be attached to the sample, for example by hybridization to complementary sequences covalently bound to the sample, or through cleavable groups.
- the nucleic acid molecules in the sample are held on the original positions by chemical- or enzyme- sensitive binding.
- chemical- or enzyme-sensitive binding Before assembly of the sample with the target surface conditions can be applied, wherein gradual release of the nucleic acid molecules from the sample occurs.
- Said conditions for gradual release of nucleic acid molecules from the sample may be the cleavage agent which acts slow enough to ignore those molecules which change the position before assembling sample against the target surface
- said low activity of the cleavage agent is provided by decreasing concentration of the said agent or by providing reaction conditions decreasing the activity of the said agent.
- Diffusion of nucleic acid molecules within the sample may be physically hindered by surrounding matrix, for example agarose or acrylamide gel. In this case diffusion exists but it is very slow: the time of appearing of free molecules on the surface of the sample is much longer than the time of assembling sample/target surface sandwich. It is possible to assemble a sandwich and wait till nucleic acid molecules diffuse enough to reach the target surface. It might be possible to speed up the diffusion by raising the temperature of the sandwich. Nucleic acid molecules may be just physically stuck within the sample, for example in gel after gel electrophoresis.
- the sample with nucleic acid molecules and the target surface are assembled under conditions where nucleic acid molecules do not go off their positions on the sample surface.
- Such conditions can comprise e.g. low temperature, a filter or net between the surfaces, enzymes and/or chemical substances preventing detachment at this stage or vice versa the lack of such enzymes and/or chemical substances needed for detachment.
- the sample with nucleic acid molecules and the target surface are assembled under "wet" conditions meaning that the sample and target surface are surrounded by solution, i.e. liquid and/or that liquid is between both surfaces. Both surfaces are arranged such that both surfaces come into contact with each other in a sandwich-like configuration. A thin liquid film can exist between both surfaces.
- the liquid between the surfaces and/or around the assembled sandwich-like configuration can comprise enzymes and/or chemical substances needed e.g. for detachment. If a filter or net between the surfaces is used during assembly, such a net would prevent direct contact of the surfaces.
- the surfaces in the sandwich-like configuration shall be tightly pressed to each other to make the distance between the surfaces so that the distance between both surfaces is so small that no blurring of the distribution pattern occurs.
- Assembling such sandwich-like configurations is performed as shown in Fig.4 and is well known to the skilled artisan and corresponds mutatis mutandis to the procedures known from e.g. western/northern blotting.
- Surface assembly would be done preferably at room or lower temperature, so that the nucleic acid molecules do not go off the sample surface.
- the inventive method does not require a direct contact between the nucleic acids distributed on the sample and the oligonucleotides on the target surface. This means that transfer may be performed between large solid surfaces, which can't form uniform tight contact.
- the incubation time is dependent from many variables, such as accessibility of the nucleic acids on the sample, incubation temperature and other factors. Generally, incubation time should be long enough to allow sufficient hybridization, but still short enough to prevent e.g. unspecific binding. Under aspects of process economy, the incubation time should be chosen to be as short as possible. The skilled artisan can determine the optimal incubation time with minimum routine experimentation.
- Detachment conditions may be applied to the assembly of the sample with distributed nucleic acid molecules and the target surface. Temperature may be applied to release nucleic acid molecules if the binding to the sample is temperature-sensitive. Thus, in one embodiment the condition for releasing the nucleic acid molecules from the original positions in the sample occurs by increasing the temperature.
- nucleic acid molecules are held on the original positions in the sample by temperature-sensitive binding by hybridization or through thermolabile covalent bonds, abasic site or formaldehyde linkage. Detachment can also occur by providing a thermoactivated cleavage agent, enzyme or chemical reagent in the solution between the sample and the target surface.
- condition for releasing the nucleic acid molecules from the original positions in the sample is changing the solution between the sample and the target surface.
- nucleic acid molecules are attached to the nucleic acid sample by hybridization to a complementary sequence, duplex may be denatured by changing the pH or ionic strength of the solution, or changing the solution to the one decreasing the denaturation temperature (like formamide).
- Nucleic acid molecules may be attached through some cleavable group.
- the cleavage agent e.g. enzyme or chemical substance
- the nucleic acid molecules are held on the original positions in the sample by hybridization and the new solution destabilizes hybridization by changing pH or ionic strength of the solution or decreasing the melting temperature of the duplex like formamide, or the nucleic acid molecules are held on the original positions in the sample by chemical- or enzyme- sensitive binding and said new solution contains a cleavage agent, and wherein either the sample or the target surface or both are permeable for the said solution and during changing of the solution the assembly remains intact.
- the integrity of the assembly is not changed, i.e. the assembly of the sample and target surface is not disassembled.
- nucleic acid molecules are attached to the sample by hybridization to a complementary sequence, duplexes may be denatured by heating the assembly.
- Nucleic acid molecules may be covalently attached to the sample through thermolabile bonds like abasic site or formaldehyde linkages. In such cases heating would destroy the binding. Binding may also be organized through enzymatically or chemically cleavable site, where cleavage enzyme or chemical reagent should be thermoactivated. Cleavage agent should then be present in the solution, but during assembling the sandwich it should not act (e.g. to prevent working of an enzyme sandwich may be assembled at low temperature) or should act slowly (e.g. low concentration, inappropriate temperature).
- light may be applied to release molecules attached to the sample through photocleavable groups. In this case either the nucleic acid on the sample or the target surface or both should be translucent for the light of the required wavelength. Sandwich should be assembled without the activating light.
- washing can be performed with known washing buffers, such as PBS or any other washing buffer known to the skilled artisan. Care should be taken not to use washing buffer, which are able to disrupt the bonding between the hybridized nucleic acid molecules and their complementary sequences.
- oligonucleotide as used herein is a short nucleic acid polymer, typically with fifty or fewer bases. Although for the purposes the present invention, the oligonucleotides can have more or less nucleic acids.
- a plurality of adapter oligonucleotides is provided.
- the adapter oligonucleotides are complementary both to the nucleic acid molecules from the sample and to the nucleic acid molecules on the target surface.
- These adapter oligonucleotides are characterized by at least two regions, wherein one region is at least partially complementary to a nucleic acid on the sample and another region is at least partially complementary to the oligonucleotides attached to the target surface.
- nucleic acids do not hybridize directly to the at least one type of oligonucleotides on the target surface but said hybridization-based binding occurs through adapter oligonucleotides which are complementary both to the nucleic acid molecules from the sample and to the nucleic acid molecules on the target surface.
- Fig.7 (B) The general mechanism is a shown in Fig.7 (B) in comparison to direct hybridization of the nucleic acids to the target surface as shown in Fig.7 (A) .
- the use of adapter oligonucleotides allows to use the same target surfaces for hybridization probes with different regions responsible for binding to the target surface.
- enzymatic reactions may be performed with the replica on the target surface, wherein said enzymatic reactions include primer extension, ligation, rolling circle amplification, in situ PCR amplification, bridge PCR amplification, sequencing, restriction (see Fig.5 and 6 ).
- nucleic acid molecules in the sample or nucleic acid molecules on the target surface contain known sequences, which (optionally) get inserted in the nucleic acid molecules from the target surface or nucleic acid molecules from the sample by primer extension or ligation reactions and said known sequences are further used for analysis of replicas, wherein said analysis may be performed on the target surface or in solution.
- said known sequences serve to distinguish the samples, target surfaces, replication experiments, wherein said known sequences are different between the samples, target surfaces, replication experiments or to determine the position of nucleic acid molecules on the target surface or in the sample and wherein said known sequences are different in different regions of the sample or of the target.
- Oligonucleotides on the target surface may contain besides the regions for hybridization-based binding of nucleic acid molecules from the sample, sequences for labeling the transferred nucleic acid molecules. Such sequences get attached to the transferred nucleic acid molecules or their derivatives (extention, ligation products) after replication by ligation or primer extension. In the following analysis of the replicated molecules or their derivatives, for example by sequencing or hybridization, the labeling sequence would reveal to which oligonucleotide a certain replicated molecule was bound.
- Labeling sequences may be used for position coding of the transferred nucleic acid molecules.
- target surface may be divided into a number of small regions (code regions), oligonucleotides in each region containing unique nucleic acid codes - a 4-100nt nucleic acid sequence.
- Coding target surface may be used for position coding of transferred nucleic acid molecules: in each code region a different nucleic acid code will be added to the nucleic acid molecules. Adding may be performed by for example ligation, primer extension in appropriate conditions.
- position-specific codes information about surface coordinates of nucleic acid molecules is recorded in the sequences of nucleic acid codes. It is then possible to remove the coded replicated nucleic acid molecules from coding surface into solution. In the course of further analysis reading of the codes gives information about original positions of nucleic acid molecules.
- the hybridization probes are transferred to a target surface with preformed coded regions - thus, hereinafter named coding surface - and coding oligonucleotides already distributed on the coding surface.
- the general procedure is that prior to transfer of the nucleic acids from the sample to the coding surface, so called code regions are created on the coding surface.
- code regions are created on the coding surface.
- the code regions can be created physically, by applying e.g. a filter or net on the original surface, wherein each "hole” in this net or filter would represent one code region. It is also possible to use beads with coding oligonucleotides attached to them, wherein each bead would correspond to one coding region.
- the code regions are not created physically but only imaginary code regions are created. This could be realized by e.g. registering the coordinates of each code region on the sample.
- the coding surface comprises a plurality of coding oligonucleotides attached to the target surface. As long as the coding surface can bind oligonucleotides to its surface, the coding surface can be of any texture.
- the coding surface consists of code regions in each code region coding oligonucleotides have a different nucleotide code. The more precise localization of transcripts is required, the smaller code regions should be used. The more code regions should be on the coding surface - the longer code regions are required to have a unique code in each code region.
- Such coding surface may be prepared for example by spotting nucleic acid codes, by making layer of beads with nucleic acid codes, by synthesizing nucleic acid codes directly on the surface.
- the transferred nucleic acids would be coded using primer extension reaction: depending on the unique nucleic acid sequence in the coding oligonucleotides, nucleic acids will be extended with a certain unique sequence.
- the primer extension mix would contain nucleotides and polymerase in an appropriate buffer. Care has to be taken that during primer extension reaction, the nucleic acids do not go off their locations. Therefore, extension should be performed at temperatures below annealing temperature of the nucleic acids.
- the result of the extension would be a double-stranded molecule, in which both stands have flanking regions required for sequencing and unique nucleic acid sequence from the coding oligonucleotides, required for revealing the original position on the original surface.
- the coded extension products can be removed from the double-stranded molecule by different methods.
- the coding surface is rinsed high-temperature ( ⁇ 95°C) solution. At high temperature, the double strands will be denatured and the non-covalently attached stands go into solution. Also high temperature inactivates the enzyme used for primer extension, so that no primer extension is possible in the solution.
- the coding oligonucleotides on the coding surface would further comprise a cleavable group. Due to this cleavable group, the whole double strand can be removed from the coding surface after destroying the cleavable group. The double strand (see Fig.9d ) may be further amplified and then sequenced.
- nucleic acid codes should stay within the coding regions.
- nucleic acid molecules may be released independently from non-used nucleic acid codes or together with them. For example, when coded nucleic acid molecules are attached to the coding surface by hybridization, and nucleic acid codes are covalently attached, nucleic acid molecules may be released from the surface by denaturizing conditions, and nucleic acid codes will remain on the surface.
- nucleic acid codes and coded replicated nucleic acid molecules are attached to the coding surface in the same way, they will be released together.
- nucleic acid codes either remain in the mixture with coded nucleic acid molecules if they do not interfere with further operations, or they would be removed, for example by size selection.
- the present invention is also directed to a coding surface with a plurality of coding regions, wherein the coding surface is covered with a plurality of coding oligonucleotides, wherein the coding oligonucleotides are characterized by a 3' part common to all coding oligonucleotides, and an individual nucleotide sequence of 4 - 100 nucleotides, characterized in that each coding region is covered only with coding oligonucleotides with the same individual nucleotide sequence of 4 - 100 nucleotides.
- the unique sequences correspond to the sequences of oligonucleotides immobilized on the Illumina sequencing flowcells;
- SH-modified oligo #001 was immobilized on five epoxy slides: on three slides - in a recognizable pattern and on the other two - over the whole surface.
- SH-modified oligo #002 was immobilized on three epoxy slides: on one slide - in a recognizable pattern and on the other two - over the whole surface.
- Cy3-labeled oligonucleotides #003 hybridized to the slide #1b_hybr was transferred to the slide #3 covered with oligo #001, complementary to #003. Cy-3 labeled oligonucleotide #003 hybridized to the slide #1 c_hybr was transferred to the slide #5 covered with oligo #002, not complementary to #003.
- Two-dimensional tissue sections are convenient objects to study distribution of molecules. Several sequential sections restore a 3D spatial location of molecules.
- transcripts in tissue sections are analyzed by in situ hybridization.
- Main restriction of this approach is the limited number of transcripts which it is possible to analyze simultaneously. The reason is that it is impossible to select considerable number of distinguishable labels for hybridization probes.
- transcripts in tissue sections may be analyzed by sequencing and ex situ hybridization.
- Hybridization probes would have the structure as shown on Fig.3A . Middle parts of probes are for hybridization to transcripts in tissue section. Flanking regions a and b are common for all probes and are required both for hybridization and sequencing on the SGS flowcell surface ( Fig.3B ).
- Hybridization probes may be selected to target from single to thousands of transcripts. They may be synthesized artificially or prepared from a sequencing library.
- oligonucleotides should be removed before transfer of hybridization probes to the SGS flowcell surface.
- Tissue section slide and SGS surface would be brought into tight contact, possibly with a net in between (see Fig.4 ).
- the distance between surfaces (or the mesh size if a net is used) should be smaller than acceptable blurring of the distribution pattern.
- a net would also prevent direct contact of the tissue section and SGS surface.
- the time of denaturation would be selected to allow enough probes to denature and move into solution between the surfaces.
- the time of hybridization would be adjusted so that enough but not too many probes are transferred to provide a necessary density of sequencing templates and so that probes do not diffuse too far away.
- the temperature would be decreased close to 0°C. At low temperature hybridization speed becomes low, which prevents attaching of probes to the wrong places on SGS surface when sandwich is disturbed. Washing of the unhybridized probes from the SGS flowcell surface would be also performed at low temperature.
- Amplification of the transferred probes on the SGS flowcell surface and further sequencing would be performed according to the known sequencing procedures.
- SGS would determine two parameters for each probe: (i) its partial or complete nucleotide sequence and (ii) position on the slide surface. Nucleotide sequence will identify which particular transcript was a target for a probe. Position of a probe on a flowcell will be set into correspondence with the position on the tissue section.
- Example 3 Analysis of transcripts in tissue sections by single molecules sequencing transfer of transcripts distribution pattern to the pattern of sequencing templates.
- the procedure looks the same as described in example 2, with the difference in sequencing approach: molecules transferred from the tissue section are sequenced directly by single-molecule sequencing approach, where transferred molecules are sequenced directly on the target surface with capturing oligonucleotides initializing the primer extension. Since no amplification on the target surface is required, only one type of oligonucleotides can be present on the sequencing surface for capturing sequencing templates by hybridization.
- the hybridization probes may have a structure as shown in Fig.8 .
- This approach may be realized using single-molecule sequencing approach like for example that of Helicos. Single molecules sequencing allows for a higher density of sequencing templates.
- Example 4 Analysis of transcripts in tissue sections by ex situ hybridization.
- In situ amplification results in ⁇ 1000 copies of transferred molecule. This allows increasing hybridization signal and thus sensitivity of transcripts analysis.
- Another advantage of this approach is that it makes possible to use same replica for several hybridizations with different probes without increase of background.
- Target molecules are covalently attached to the surface, so it is possible to use stringent conditions to wash off probes from previous hybridization. This increases the throughput of analysis in comparison to in situ hybridization.
- Example 5a Marking positions of transcripts in tissue section by nucleic acid codes using a coding surface and subsequent analysis by SGS sequencing
- Fig.10 The general scheme of the method is shown in Fig.10 .
- This method allows to transfer transcripts (or corresponding to transcripts hybridization probes, primer extension products) from tissue section into solution preserving information about the distribution pattern.
- Molecules in the solution may be further processed according to standard sequencing protocols for sample preparation. Loading of sequencing flowcell would be performed as for standard sequencing library, so loading density will be even over the flowcell surface and adjustable. Having sequencing templates in the solution would also allow to use any SGS platform and thus be independent from the SGS surface.
- Hybridization probes would have the structure as shown on figure 9A . Middle parts of probes are for hybridization to transcripts in tissue section. Flanking regions are common for all probes and are required for hybridization to the coding surface (hybr. region) and sequencing on the SGS flowcell surface (seq. region 1).
- Coding surface is covered with covalently attached coding oligonucleotides. Structure of coding oligonucleotides is shown on Fig.9B . The 3' part, which is complementary to the hybridization region of the hybridization probes, is followed by code region. 5' part is required for further sequencing on the SGS flowcell (seq. region 2). Coding oligo may be detached from the surface using a cleavage site. Cleavage site may be organised for example by a chemically, thermally or enzymatically destroyable nucleotide.
- Coding surface consists of coding regions, in each region coding oligos have a different code part. The more precise localisation of transcripts is required, the smaller coding regions should be used. The more coding regions should be on the surface - the longer code region is required to have a unique code in each region.
- Hybridized probes would be transferred to a coding surface as described in the example 2. Attachment to the coding surface would be realized by hybridisation of the hybridization region of the hybridization probes to the complementary 3' part of the oligos on the coding surface ( Fig. 9B ). The result of the transfer would be a coding surface with hybridization probes attached to it in a mirror-distribution relative to the distribution of corresponding transcripts in tissues section.
- Transferred hybridization probes would be coded using primer extension reaction ( Fig. 9C ): depending on the coding region, hybridization probe will be extended with a certain code sequence.
- Primer extension mix would contain nucleotides and polymerase in an appropriate buffer. Mix would be pipetted over the surface using for example HybriWell chambers from Grace Biolabs. It is important that during primer extension reaction, hybridization probes do not go off their locations. Extension should therefore be performed at temperatures below annealing temperature of hybridization region.
- the result of the extension would be double-stranded molecules, in which both strands have flanking regions required for sequencing and code regions, required for revealing molecules position ( Fig. 9C ).
- Coded molecules can be removed from the slide and combined in the solution. This may be performed in two ways.
- Coding surface would be rinsed in high-temperature ( ⁇ 95°C) solution. At high temperature, duplexes will be denatured and non-covalently attached strands will go into solution. Also high temperature would inactivate the enzyme used for primer extension, so that no primer extension would be possible in the solution (which may cause chimeric molecules formation).
- Single-stranded sequencing templates have common flanking regions required for SGS and may be further amplified or used directly for clonal amplification.
- Duplexes would be removed from the coding surface after destroying of the cleavable group. Together with duplexes, non-extended coding oligos will also be removed from the coding surface, and may cause extension in solution, which may lead to wrong coding and formation of chimeric molecules. It is therefore necessary to pay attention that polymerase present in primer extention mix is washed away from the surface or inactivated prior to combining the duplexes in solution. Double-stranded sequencing templates ( Fig. 9D ) may be further amplified or used directly for clonal amplification.
- SGS would determine two sequences for each sequencing template: (i) partial or complete transcript-specific sequence and (ii) sequence of the code.
- Code sequence will be set into correspondence with the distribution scheme of position coding primers on the tissue section slide, and reveal the initial position of the transcript in the tissue section.
- Example 5b Marking positions of nucleic acids in tissue section with a sequenced SOLiD flowcell as a coding surface and subsequent analysis by Second Generation Sequencing (SGS)
- sequences may serve as codes for hybridization probes transferred from tissue section slide ( Fig.12 ).
- Hybridization probes would have the structure as shown on Fig.11 . Middle parts of probes are for hybridization to transcripts in tissue section. Flanking regions are common for all probes and are required for hybridization to the coding surface (hybridization region) and sequencing on the Illumina platform (illumination region 1). Hybridization region may hybridize to the common 3' region (P2) of SOLiD sequencing templates.
- Coding surface is a sequenced SOLiD flowcell: glass slide covered with beads. Each bead is a different code region. Unique middle parts of sequencing templates serve as codes ( Fig. 11 B) .
- Hybridized probes would be transferred to the coding surface as described in the example 2. Attachment to the sequencing templates would be realized by hybridization of the hybridization region of the hybridization probes to the complementary P2 regions ( Fig. 11 C) . The result of the transfer would be beads with hybridization probes attached to them.
- Transferred hybridization probes would be coded using primer extension reaction ( Fig. 11 D) : depending on the bead to which it is attached, hybridization probe will be extended with a certain code sequence.
- Primer extension mix would contain nucleotides and polymerase in an appropriate buffer. Mix would be pipetted over the surface using for example HybriWell chambers from Grace Biolabs. It is important that during primer extension reaction, hybridization probes do not go off their locations. Extension should therefore be performed at temperatures below annealing temperature of hybridization region. Sequencing templates would not be extended because in the course of the SOLiD sequencing protocol they are 3' end blocked.
- the result of the extension would be a hybridization probe to which the sequence of a SOLiD sequencing template is added, and which has a P1 sequence on 3'end ( Fig. 11E ).
- Coded molecules may be washed off the beads in denaturizing conditions and combined in solution. Single stranded coded molecules would be amplified to introduce illumination region 2 next to P1 part of the molecule.
- Result of amplification would be double-stranded molecules flanked with Illumina-platform specific illumination regions 1 and 2 ( Fig.11F ), which may be further amplified or used directly for clonal amplification and sequencing on the Illumina platform.
- Illumina sequencing would determine two sequences for each sequencing template: (i) partial or complete transcript-specific sequence and (ii) sequence of the code. Code sequences will reveal the position of corresponding beads on the SOLiD flowcell and thus the position of original transcripts in the tissue section.
- Example 6 Analysis of a panel of samples with 2D distributed nucleic acid molecules.
- nucleic acid molecules e.g. cell arrays, tissue arrays
- coding is used to mark nucleic acid molecules from a single sample, size of coding regions on the coding surface may be comparable to the size of a sample.
- Example 7 Using surfaces covered with oligonucleotides for selective replication.
- Replication method using holding nucleic acid molecules on the target surface by hybridization is highly selective. From a mix of nucleic acid molecules transferred from a sample with 2D distributed nucleic acid molecules to the target surface, only those will be replicated, which have a sequence complementary to the capturing oligonucleotides.
- Selectivity may be used for example for selection of full-length oligonucleotides after on-surface synthesis. Oligonucleotides synthesis is performed from 3' to 5' end. For selection of full-length oligos it is possible to use 5' sequences. In the Fig.13A all synthesized oligonucleotides should have the same 5' region. Oligonucleotides complementary to this region are attached to the target surface. During replication of synthesized oligos to the target surface, only full length oligonucleotides get captured.
- oligonucleotides synthesized in each array feature have a different 5' region. Capturing oligonucleotides complementary to these 5' regions are synthesized on another array. Features are located in such a way that complementary sequences during replication are opposite to each other.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
The present invention provides methods for preserving information about original spatial distribution of nucleic acid molecules transferred from a sample to another surface or into solution.
Description
- In the present invention a replica of distributed nucleic acid molecules is created by hybridization of nucleic acids located on a surface or within a layer of a sample to a target surface by hybridization to complementary sequences. Target surface may be for example covered with oligonucleotides, complementary to the nucleic acids on the sample or hybridization may occur through adapter oligonucleotides complementary both to the oligos on the target surface and to the nucleic acid molecules on the sample.
- Biological processes are spatially organized. They rely upon the interplay of many different components forming an intricate structure of cells, tissues and organisms. Molecules participating in these processes have a certain spatial distribution. Understanding the biological processes is critically dependent on a detailed knowledge of this distribution.
- Objects with two-dimensional distribution of nucleic acid molecules, for example tissue sections, are widely studied. There exist methods for nucleic acid analysis in tissue sections, for example in situ hybridization or in situ PCR. However, not all molecular biology methods are applicable when working with tissue sections.
- Two-dimensional tissue sections are convenient objects to study distribution of molecules. Several sequential sections restore a 3D spatial location of molecules. However, many molecular biology methods, for example sequencing, cannot be performed directly in tissue sections. It would be advantageous to be able to transfer molecules from the tissue section to another surface or into solution, where appropriate methods of analysis could be performed. However, such transfer raises questions of keeping information about initial distribution of the nucleic acid molecules.
- Replication of 2D distributed objects (nucleic acid molecules, cells) has been long used in molecular biology. Main purposes are to perform analysis which is not possible with original sample and (ii) multiplying 2D sample for several analyses.
- Southern and Northern methods are known, wherein nucleic acid molecules are transferred from gel to membrane. Membrane allows analyzing transferred molecules by hybridization preserving the relative distribution they had in gel. Replica of DNA of library clones on membranes is used to search for particular clones using hybridization. Replication of bacterial colonies to other plates allows analyzing in parallel, for example, their resistance to several antibiotics.
- In the last decade, two methods were suggested for multiplying nucleic acid arrays by replication. In one approach nucleic acid array features are first amplified on the array, then the array with amplified features is brought into tight contact with transfer support, to which parts of amplified molecules are transferred and get covalently attached (
U.S. Patent 7,785,790 ). In the nanostamping approach nucleic acid molecules hybridised to sample surface are brought into direct contact with capturing groups on the target surface. Chemical binding with the target surface is stronger than hybridization and after separating surfaces, nucleic acid molecules remain on the target surface (U.S. Patent 7,862,849 ). - The general principle of replication is bringing into contact a surface with 2D distributed nucleic acid molecules with a target surface, to which they are transferred by diffusion or direct contact. So far nucleic acid molecules have been transferred to surfaces were they were captured either physically (stuck in gel) or by chemical bonds (covalent, ion exchange, affinity) involving certain reactive groups on the nucleic acid molecules and on the target surface, but not involving the nucleotide sequence of the molecules.
- Objective of the present invention is to provide a method capable of preserving the information about spatial distribution of nucleic acid molecules transferred from a surface to another surface.
- This objective is solved by the present methods as shown below. Further preferred embodiments of the present invention are disclosed in the dependent claims, the description, the figures and the examples.
- Surprisingly it was found that methods according to the present invention allow the transfer of nucleic acid molecules to another surface preserving information about their original positions.
- The present invention is directed to methods for preserving information about original spatial distribution of nucleic acid molecules transferred from a surface to another surface or into solution.
- This is accomplished by the use of hybridization of nucleic acids for creating replicas of nucleic acids molecules or molecular complexes containing nucleic acid molecules located either on a surface or within a layer, wherein said creating replicas is obtaining on a target surface the relative distribution of nucleic acid molecules or molecular complexes containing nucleic acid molecules resembling the original distribution.
- Hybridization as a way to capture nucleic acid molecules makes the replication highly selective, since only nucleic acid molecules having complementary sequences will be hold on the target surface. Besides, hybridization is a controllable process and allows regulation of the time of replication and, consequently, the number of transferred nucleic acid molecules. The method does not require direct contact of 2D distributed nucleic acid molecules to binding sites on the target surface. This means that (i) the transfer may be performed between large solid surfaces, which can't form uniform tight contact and (ii) the method may be applied to transfer nucleic acid molecules from 3D samples to the target surface.
- The term "replica" as used herein refers to a copy of the distribution of nucleic acids with preservation of their original distribution to a target surface by hybridization. The target surface with the transferred nucleic acids held by hybridization with preservation of their original distribution is the created replica. Thus, replica is obtaining on a target surface the relative distribution of nucleic acid molecules or molecular complexes containing nucleic acid molecules resembling the original distribution.
- The replication method according to the invention comprises the following steps:
- a) providing sample with nucleic acid molecules located either on a surface or within a layer;
- b) providing target surface with nucleic acid molecules, capable to hybridization-based binding to nucleic acid molecules from (a);
- c) (option 1) if nucleic acid molecules are not attached to the sample, providing conditions to minimize shift of molecules from the original positions;
- d) (option 2) if nucleic acid molecules are attached to the sample, providing conditions for gradual releasing of nucleic acid molecules;
- e) assembling sample with nucleic acid molecules from (a) against the target surface from (b) with solution in between, such that nucleic acid molecules from the sample can reach target surface by diffusion through solution;
- f) (option 3) if nucleic acid molecules are attached to the sample, providing conditions for releasing nucleic acid molecules from the original positions in the sample,
- g) providing conditions for diffusion of nucleic acid molecules from the sample to the target surface and hybridization-based binding of nucleic acid molecules from the sample to the nucleic acid molecules on the target surface;
- h) (optional) providing conditions for slowing down the formation of new hybrids of nucleic acid molecules;
- i) disassembling the sample (a) and target surface (b).
- The nucleic acid molecules can be either located on the surface of the sample or within a layer of the sample. Preferably, the nucleic acid molecules located on a surface or within the layer are distributed on a nucleic acid array or protein array, and wherein said nucleic acid molecules distributed within a layer are distributed in a gel layer, in tissue section, in cell or tissue array or in block of tissue. For example, the nucleic acids can be contained in a gel and can be mobilized out of the gel to the surface of the gel. Alternatively, the nucleic acids can be provided on a glass slide.
- The sample with nucleic acid molecules also comprises nucleic acids that are hybridized to the nucleic acids on the sample. This means that nucleic acids could be distributed on the sample and to this nucleic acids further nucleic acids are hybridized. Thus providing a sample with nucleic acids molecules located either on a surface or within a layer also includes hybridization products of nucleic acids. Consequently, the term nucleic acids also comprise hybridization products of nucleic acids.
- The target surface comprises a plurality of at least one type of oligonucleotides attached to the target surface. The target surface can be of any texture. The target surface should be covered with oligonucleotides, at least in the area to which the transfer is performed. Transferred nucleic acid molecules hybridize preferably directly to the oligonucleotides immobilized on the target surface.
- A lot of ways are known in the prior art for preparation of surfaces covered with oligonucleotides, e.g. spotting, on-surface synthesis, attaching to beads, fixation in gel, etc.
- The nucleic acids may be either attached or not attached to the sample. If the nucleic acids are not attached to the sample it is preferred to apply conditions to minimize the shift of nucleic acid molecules from their respective original positions. Such conditions could be the decrease of temperature. Preferably, the temperature is decreased below 24°C, preferably 20°C, more preferably 16°C, preferably 12°C, even more preferred 8°C, and more preferred 4°C.
- On the other hand if the nucleic acids are attached to the sample it may be advisable to apply conditions, wherein gradual release of the nucleic acids in the sample occurs. The nucleic acids may be attached to the sample, for example by hybridization to complementary sequences covalently bound to the sample, or through cleavable groups.
- In one embodiment the nucleic acid molecules in the sample are held on the original positions by chemical- or enzyme- sensitive binding. Thus before assembly of the sample with the target surface conditions can be applied, wherein gradual release of the nucleic acid molecules from the sample occurs. Said conditions for gradual release of nucleic acid molecules from the sample may be the cleavage agent which acts slow enough to ignore those molecules which change the position before assembling sample against the target surface
- In one embodiment said low activity of the cleavage agent is provided by decreasing concentration of the said agent or by providing reaction conditions decreasing the activity of the said agent.
- Diffusion of nucleic acid molecules within the sample may be physically hindered by surrounding matrix, for example agarose or acrylamide gel. In this case diffusion exists but it is very slow: the time of appearing of free molecules on the surface of the sample is much longer than the time of assembling sample/target surface sandwich. It is possible to assemble a sandwich and wait till nucleic acid molecules diffuse enough to reach the target surface. It might be possible to speed up the diffusion by raising the temperature of the sandwich. Nucleic acid molecules may be just physically stuck within the sample, for example in gel after gel electrophoresis.
- The sample with nucleic acid molecules and the target surface are assembled under conditions where nucleic acid molecules do not go off their positions on the sample surface. Such conditions can comprise e.g. low temperature, a filter or net between the surfaces, enzymes and/or chemical substances preventing detachment at this stage or vice versa the lack of such enzymes and/or chemical substances needed for detachment.
- Preferably the sample with nucleic acid molecules and the target surface are assembled under "wet" conditions meaning that the sample and target surface are surrounded by solution, i.e. liquid and/or that liquid is between both surfaces. Both surfaces are arranged such that both surfaces come into contact with each other in a sandwich-like configuration. A thin liquid film can exist between both surfaces. The liquid between the surfaces and/or around the assembled sandwich-like configuration can comprise enzymes and/or chemical substances needed e.g. for detachment. If a filter or net between the surfaces is used during assembly, such a net would prevent direct contact of the surfaces.
- The surfaces in the sandwich-like configuration shall be tightly pressed to each other to make the distance between the surfaces so that the distance between both surfaces is so small that no blurring of the distribution pattern occurs. Assembling such sandwich-like configurations is performed as shown in
Fig.4 and is well known to the skilled artisan and corresponds mutatis mutandis to the procedures known from e.g. western/northern blotting. Surface assembly would be done preferably at room or lower temperature, so that the nucleic acid molecules do not go off the sample surface. Generally, the inventive method does not require a direct contact between the nucleic acids distributed on the sample and the oligonucleotides on the target surface. This means that transfer may be performed between large solid surfaces, which can't form uniform tight contact. - The terms "sandwich-like configuration" or "assembly" both refer to the configuration that the sample and the target surface are brought into contact with each other.
- The incubation time is dependent from many variables, such as accessibility of the nucleic acids on the sample, incubation temperature and other factors. Generally, incubation time should be long enough to allow sufficient hybridization, but still short enough to prevent e.g. unspecific binding. Under aspects of process economy, the incubation time should be chosen to be as short as possible. The skilled artisan can determine the optimal incubation time with minimum routine experimentation.
- Detachment conditions (certain temperature, light, solution) may be applied to the assembly of the sample with distributed nucleic acid molecules and the target surface. Temperature may be applied to release nucleic acid molecules if the binding to the sample is temperature-sensitive. Thus, in one embodiment the condition for releasing the nucleic acid molecules from the original positions in the sample occurs by increasing the temperature.
- In another embodiment the nucleic acid molecules are held on the original positions in the sample by temperature-sensitive binding by hybridization or through thermolabile covalent bonds, abasic site or formaldehyde linkage. Detachment can also occur by providing a thermoactivated cleavage agent, enzyme or chemical reagent in the solution between the sample and the target surface.
- Hence, in another embodiment the condition for releasing the nucleic acid molecules from the original positions in the sample is changing the solution between the sample and the target surface.
- The possibility to change solution in the contact area in the assembly substantially increases the variants of nucleic acid molecules attachment to the sample, and consequently, types of samples. If nucleic acid molecules are attached to the nucleic acid sample by hybridization to a complementary sequence, duplex may be denatured by changing the pH or ionic strength of the solution, or changing the solution to the one decreasing the denaturation temperature (like formamide). Nucleic acid molecules may be attached through some cleavable group. The cleavage agent (e.g. enzyme or chemical substance) may be delivered after the sandwich assembly.
- In yet another embodiment the nucleic acid molecules are held on the original positions in the sample by hybridization and the new solution destabilizes hybridization by changing pH or ionic strength of the solution or decreasing the melting temperature of the duplex like formamide, or the nucleic acid molecules are held on the original positions in the sample by chemical- or enzyme- sensitive binding and said new solution contains a cleavage agent, and wherein either the sample or the target surface or both are permeable for the said solution and during changing of the solution the assembly remains intact. Thus, only the solution is changed but the integrity of the assembly is not changed, i.e. the assembly of the sample and target surface is not disassembled.
- If nucleic acid molecules are attached to the sample by hybridization to a complementary sequence, duplexes may be denatured by heating the assembly. Nucleic acid molecules may be covalently attached to the sample through thermolabile bonds like abasic site or formaldehyde linkages. In such cases heating would destroy the binding. Binding may also be organized through enzymatically or chemically cleavable site, where cleavage enzyme or chemical reagent should be thermoactivated. Cleavage agent should then be present in the solution, but during assembling the sandwich it should not act (e.g. to prevent working of an enzyme sandwich may be assembled at low temperature) or should act slowly (e.g. low concentration, inappropriate temperature). In one embodiment light may be applied to release molecules attached to the sample through photocleavable groups. In this case either the nucleic acid on the sample or the target surface or both should be translucent for the light of the required wavelength. Sandwich should be assembled without the activating light.
- Under certain conditions it may be necessary to wash the sample after incubation. Washing can be performed with known washing buffers, such as PBS or any other washing buffer known to the skilled artisan. Care should be taken not to use washing buffer, which are able to disrupt the bonding between the hybridized nucleic acid molecules and their complementary sequences.
- An "oligonucleotide" as used herein is a short nucleic acid polymer, typically with fifty or fewer bases. Although for the purposes the present invention, the oligonucleotides can have more or less nucleic acids.
- Before separating the surfaces, it may be necessary to decrease the temperature close to 0°C. At low temperature hybridization speed becomes low, which prevents attaching of nucleic acids to the wrong places on the target surface when the sandwich-like configuration is disturbed. Optionally, washing of the target surface may be performed at low temperature. Thus, in one embodiment before disassembling the sample and the target surface slowing down formation of new hybrids of nucleic acid molecules is done by decreasing the temperature of the assembly.
- In one embodiment a plurality of adapter oligonucleotides is provided. The adapter oligonucleotides are complementary both to the nucleic acid molecules from the sample and to the nucleic acid molecules on the target surface. These adapter oligonucleotides are characterized by at least two regions, wherein one region is at least partially complementary to a nucleic acid on the sample and another region is at least partially complementary to the oligonucleotides attached to the target surface. In this embodiment the nucleic acids do not hybridize directly to the at least one type of oligonucleotides on the target surface but said hybridization-based binding occurs through adapter oligonucleotides which are complementary both to the nucleic acid molecules from the sample and to the nucleic acid molecules on the target surface.
- The general mechanism is a shown in
Fig.7 (B) in comparison to direct hybridization of the nucleic acids to the target surface as shown inFig.7 (A) .The use of adapter oligonucleotides allows to use the same target surfaces for hybridization probes with different regions responsible for binding to the target surface. - After the nucleic acids from the sample have been transferred to the target surface enzymatic reactions may be performed with the replica on the target surface, wherein said enzymatic reactions include primer extension, ligation, rolling circle amplification, in situ PCR amplification, bridge PCR amplification, sequencing, restriction (see
Fig.5 and6 ). - In yet another embodiment the nucleic acid molecules in the sample or nucleic acid molecules on the target surface contain known sequences, which (optionally) get inserted in the nucleic acid molecules from the target surface or nucleic acid molecules from the sample by primer extension or ligation reactions and said known sequences are further used for analysis of replicas, wherein said analysis may be performed on the target surface or in solution.
- In another embodiment the said known sequences serve to distinguish the samples, target surfaces, replication experiments, wherein said known sequences are different between the samples, target surfaces, replication experiments or to determine the position of nucleic acid molecules on the target surface or in the sample and wherein said known sequences are different in different regions of the sample or of the target.
- Oligonucleotides on the target surface may contain besides the regions for hybridization-based binding of nucleic acid molecules from the sample, sequences for labeling the transferred nucleic acid molecules. Such sequences get attached to the transferred nucleic acid molecules or their derivatives (extention, ligation products) after replication by ligation or primer extension. In the following analysis of the replicated molecules or their derivatives, for example by sequencing or hybridization, the labeling sequence would reveal to which oligonucleotide a certain replicated molecule was bound.
- Labeling sequences may be used for position coding of the transferred nucleic acid molecules. For example, target surface may be divided into a number of small regions (code regions), oligonucleotides in each region containing unique nucleic acid codes - a 4-100nt nucleic acid sequence. Coding target surface may be used for position coding of transferred nucleic acid molecules: in each code region a different nucleic acid code will be added to the nucleic acid molecules. Adding may be performed by for example ligation, primer extension in appropriate conditions. By adding position-specific codes, information about surface coordinates of nucleic acid molecules is recorded in the sequences of nucleic acid codes. It is then possible to remove the coded replicated nucleic acid molecules from coding surface into solution. In the course of further analysis reading of the codes gives information about original positions of nucleic acid molecules.
- In these embodiments the hybridization probes are transferred to a target surface with preformed coded regions - thus, hereinafter named coding surface - and coding oligonucleotides already distributed on the coding surface.
- The general procedure is that prior to transfer of the nucleic acids from the sample to the coding surface, so called code regions are created on the coding surface. Thus the coding surface is subdivided in any number of code regions, the number of code regions being dependent on the desired resolution. The code regions can be created physically, by applying e.g. a filter or net on the original surface, wherein each "hole" in this net or filter would represent one code region. It is also possible to use beads with coding oligonucleotides attached to them, wherein each bead would correspond to one coding region. However, it is also possible that the code regions are not created physically but only imaginary code regions are created. This could be realized by e.g. registering the coordinates of each code region on the sample. The coding surface comprises a plurality of coding oligonucleotides attached to the target surface. As long as the coding surface can bind oligonucleotides to its surface, the coding surface can be of any texture. The coding surface consists of code regions in each code region coding oligonucleotides have a different nucleotide code. The more precise localization of transcripts is required, the smaller code regions should be used. The more code regions should be on the coding surface - the longer code regions are required to have a unique code in each code region.
- Such coding surface may be prepared for example by spotting nucleic acid codes, by making layer of beads with nucleic acid codes, by synthesizing nucleic acid codes directly on the surface.
- The transferred nucleic acids would be coded using primer extension reaction: depending on the unique nucleic acid sequence in the coding oligonucleotides, nucleic acids will be extended with a certain unique sequence. The primer extension mix would contain nucleotides and polymerase in an appropriate buffer. Care has to be taken that during primer extension reaction, the nucleic acids do not go off their locations. Therefore, extension should be performed at temperatures below annealing temperature of the nucleic acids.
- The result of the extension would be a double-stranded molecule, in which both stands have flanking regions required for sequencing and unique nucleic acid sequence from the coding oligonucleotides, required for revealing the original position on the original surface. The coded extension products can be removed from the double-stranded molecule by different methods. In one embodiment the coding surface is rinsed high-temperature (∼95°C) solution. At high temperature, the double strands will be denatured and the non-covalently attached stands go into solution. Also high temperature inactivates the enzyme used for primer extension, so that no primer extension is possible in the solution.
- In another embodiment, the coding oligonucleotides on the coding surface would further comprise a cleavable group. Due to this cleavable group, the whole double strand can be removed from the coding surface after destroying the cleavable group. The double strand (see
Fig.9d ) may be further amplified and then sequenced. - It should be taken into consideration, that during transfer of nucleic acid molecules to the coding surface and during adding of nucleic acid codes to the nucleic acid molecules, nucleic acid codes should stay within the coding regions. Depending on the way of attachment of coded replicated nucleic acid molecules to the coding surface, nucleic acid molecules may be released independently from non-used nucleic acid codes or together with them. For example, when coded nucleic acid molecules are attached to the coding surface by hybridization, and nucleic acid codes are covalently attached, nucleic acid molecules may be released from the surface by denaturizing conditions, and nucleic acid codes will remain on the surface. When both nucleic acid codes and coded replicated nucleic acid molecules are attached to the coding surface in the same way, they will be released together. In the latter case nucleic acid codes either remain in the mixture with coded nucleic acid molecules if they do not interfere with further operations, or they would be removed, for example by size selection.
- The present invention is also directed to a coding surface with a plurality of coding regions, wherein the coding surface is covered with a plurality of coding oligonucleotides, wherein the coding oligonucleotides are characterized by a 3' part common to all coding oligonucleotides, and an individual nucleotide sequence of 4 - 100 nucleotides, characterized in that each coding region is covered only with coding oligonucleotides with the same individual nucleotide sequence of 4 - 100 nucleotides.
-
- Fig. 1:
- Cy3-labeled oligonucleotides #003 was hybridized to the
slides # 1a (with oligonucleotides #001 deposited to formfigure "1 ") and to the slide #2 (with oligonucleotides #002 deposited to formfigure "2 "). - Fig. 2:
- Transfer of Cy3-labeled
oligonucleotide # 003 hybridized to theslide # 1 b_hybr to theslide # 3. The surface of thetarget slide # 3 is covered with covalently immobilised oligonucleotides #001 (grey area), which is complementary to #003. - Fig. 3:
- (A) Structure of hybridization probe with two flanking regions suitable both for (i) hybridization to nucleic acids on sample surface and for (ii) second generation sequencing. (B) Scheme of the probe hybridization to the target surface. The target surface is covered with attached oligonucleotides - 1 and - 2. Oligonucleotides - 2 hybridizes with region b of the hybridization probe, providing attachment to the target surface. Oligonucleotides - 1 hybridizes with sequence complementary to region a of the hybridization probe, making possible the on-surface amplification and second generation sequencing.
- Fig. 4:
- Scheme of transfer of hybridization probes from sample surface to the target surface
- Fig. 5:
- Examples of enzymatic reactions which may be performed with hybridization probes on the target surface. Hybridization probes can be sequenced on the target surface, using the oligonucleotides on the target surface to start sequencing-by-synthesis. Hybridization probes may be amplified, for example by rolling circle amplification (RCA), in situ PCR or bridge PCR.
- Fig. 6:
- Scheme of rolling circle amplification of the hybridization probe. Hybridization probe is circularised and amplified using oligonucleotides on the target surface first as a template for ligation and then as a primer for amplification.
- Fig. 7:
- Examples of attaching hybridization probes on the target surface by hybridization. (A) Hybridization of hybridization probes directly to the oligonucleotides attached to the target surface. (B) Binding to the target surface by hybridization to adapter oligonucleotides.
- Fig. 8:
- (A) Structure of hybridization probe with one flanking region suitable both for (i) hybridization to nucleic acids on sample surface and for (ii) second generation sequencing. (B) Scheme of the probe hybridization to the target surface. The target surface is covered with attached oligonucleotides. The oligonucleotides hybridize with region "a" of the hybridization probe, providing attachment to the target surface. Second generation sequencing can be performed without amplification according to true single molecule sequencing tSMS™ (Helicos).
- Fig. 9:
- (A) Structure of hybridization probe suitable for (i) hybridization to complementary sequences on sample surface, (ii) hybridization to the coding surface and having seq.
region 1 necessary for second generation sequencing. (B-D) Scheme of adding a code to hybridization probes using primer extension. Oligonucleotides attached to the coding surface have 3' end necessary for hybridization to the hybridization probes transferred from sample surface, code region to mark the location of the hybridization probes and seq.region 2 required for second generation sequences (B). To add codes and seq.region 2 to hybridization probes, extension reaction is performed (C). Resulting double-stranded molecules suitable for second generation sequencing are cleaved from the surface (D) and combined in solution. - Fig. 10:
- Scheme of position coding involving coding surface. Hybridization probes are transferred to a coding surface
- Fig. 11:
- (A) Structure of hybridization probe suitable for (i) hybridization to transcripts in tissue section, (ii) hybridization to the SOLiD P1 region of sequencing templates and having illum.
region 1 necessary for Illumina SGS. (B) Structure if the SOLiD sequencing template attached to the bead. (C-F) Scheme of adding a code to hybridization probes using primer extension. Hybridization probes transferred from tissue section slide hybridize to the P2 region (C). Hybridization probes are extended (D). Internal sequence of the sequencing template which marks the position of the bead on the SOLiD flowcell is now added to the hybridization probe sequence, thus marking the position of the transfer nd of original transcript in tissue section. To introduce illum.region 2 necessary for Illumina SGS, coded hybridization probes are PCR amplified. One of PCR primers has a P1-complementary 3' end and illum.region 2 5' tail; another primer correspond to illum. region 1 (E). Resulting double-stranded molecules are suitable for Illumina SGS. - Fig. 12:
- Position coding involving sequenced SOLiD flowcell as a coding surface. Hybridization probes are transferred to a coding surface covered with beads. Each bead is characterised by a specific coding sequence.
- Fig. 13:
- Selective replication of full-length oligonucleotides by hybridization to the sequences complementary to the 5' end of oligonucleotides. (A) Full-length oligonucleotides have the same sequence on 5' end. (B) Full-length oligonucleotides in each feature of the oligonucleotide array have a different sequence on 5' end. In this case target surface is organized as an array of features with oligonucleotides complementary to full-length oligos in the corresponding features of oligonucleotide synthesis surface.
-
- ● Epoxy-modified glass slides: Nexterion Epoxysilane 2-D surface Slide E kit (Schott, #1066643)
- ● Hybridization chambers: Secure Seal (Grace bio-labs, #SA500)
- ● Oligonucleotides:
- ■ SH-modified oligonucleotides for immobilization on the epoxy slides:
- #001 5' SH-TTTTTTTTTTAATGATACGGCGACCACCGA 3' (SEQ ID NO:1)
- #002 5' SH-TTTTTTTTTTCAAGCAGAAGACGGCATACGA 3' (SEQ ID NO:2)
- ■ SH-modified oligonucleotides for immobilization on the epoxy slides:
- The unique sequences correspond to the sequences of oligonucleotides immobilized on the Illumina sequencing flowcells;
- ■ Cy3-labeled fluorescent hybridization probe:
- #003 5' Cy3-AGAGTGTAGATCTCGGTGGTCGCCGTATCATT 3' (SEQ ID NO:3)
- Partly complementary to oligonucleotides #001, complementary sequence is underlined.
- SH-modified oligo #001 was immobilized on five epoxy slides: on three slides - in a recognizable pattern and on the other two - over the whole surface. SH-modified oligo #002 was immobilized on three epoxy slides: on one slide - in a recognizable pattern and on the other two - over the whole surface.
- 1. 40 µM SH-modified oligos were diluted to 20 µM by adding the equal volume of the 2x Nexterion Spot solution.
- 2. Oligo solutions were deposited on slides:
- ●
Slides # 1a, #1b and #1c: 1 µl drops of oligo #001 were deposited to form afigure "1 " (seefigure 1 , #1a) - ● Slide #2: 1 µl drops of oligo #002 were deposited to form a
figure "2 " (seefigure 1 , #2) - ● Slides #3&4: were laid upon each other with 3 mm wide and 0.2 mm thick spacers along the long sides and oligo #001 was pipetted to fill the space between the two slides;
- ● Slides #5&6: were laid upon each other with 3 mm wide and 0.2 mm thick spacers along the long sides and oligo #002 was pipette to fill the space between the two slides.
- ●
- Further all slides (#1a, b, c - 6) were handled the same way.
- 3. Slides with deposited oligonucleotides were incubated in a humidity chamber at room temperature for 30 min to ensure quantitative immobilization.
- 4. Slides were washed at room temperature:
- ● for 5 min in 0.1 % Triton® X-1 00;
- ● two times for 2 min in 1 mM HCl solution;
- ● for 10 min in 100 mM KCI solution;
- ● for 1 min in bidistilled water.
- 5. Blocking was performed:
- ● incubating for 15 min in 1x Nexterion Blocking Solution at 50°C;
- ● rinsing for 1 min in bidistilled water at room temperature.
- 6. Slides with immobilized oligonucleotides were dried under nitrogen stream and stored in dry atmosphere in an excicator.
-
- 1. Cy3-labeled oligonucleotides #003 solution was prepared: 10 nM oligo in 90 % Nexterion Hybridization buffer.
- 2. Hybridization chambers were placed over the areas with spots on
slides # 1a, #1b, #1c and #2, the labelled oligonucleotides solution was added to the chamber. - 3. Slides were incubated for 1 hour at 42°C in the PCR machine with glass slides adapter.
- 4. Hybridization chambers were removed and slides were washed at room temperature:
- ● for 10 min in (2x SSC, 0.2 % SDS);
- ● for 10min in 2x SSC;
- ● for 10min in 0.2x SSC.
- 5.
Slides # 1b and #1c with hybridized Cy-3 labeled oligo (#1b_hybr and #1c_hybr) were left in 0.2x SSC at room temperature for ∼ 1 hour, till the transfer experiment was performed. - 6.
Slides # 1a and #2 with hybridized Cy-3 labeled oligo (#1a_hybr and #2_hybr) were dried under nitrogen stream and scanned on the Affymetrix 428 Array Scanner. - On slide #1a_hybr a fluorescent pattern of the
figure "1 " was obtained (seeFig. 1 ). No fluorescent signal was observed on the slide #2_hybr. - Cy3-labeled oligonucleotides #003 hybridized to the slide #1b_hybr was transferred to the
slide # 3 covered with oligo #001, complementary to #003. Cy-3 labeledoligonucleotide # 003 hybridized to theslide # 1 c_hybr was transferred to the slide #5 covered with oligo #002, not complementary to #003. - 1. ∼25 µl of Nexterion Hybridization bhuffer was pipetted on the oligo covered surfaces of
slides # 3 and #5, to which the Cy-3 labeled oligo had to be transferred. - 2. Slides #1b_hybr and #1c_hybr with the hybridized
fluorescent oligonucleotide # 003 were placed over the drop of Nexterion Hybridization buffer onslides # 3 and #5 respectively. - 3. The sandwiches of slides #1b_hybr / #3 and #1c_hybr / #5 were placed in separate plastic bags.
- 4. The slides in both sandwiches were pressed tightly to each other with paper clips to let the hybridization buffer squeeze out into the bag.
- 5. Bags with slide sandwiches were placed in a beaker with boiling water for 3min.
- 6. Bags were transferred to a beaker with 42°C water for 15 min.
- 7. Bags were transferred to room temperature; sandwiches were taken out and disassembled. All slides were washed, blocked, dried out and scanned as described in the "Hybridization" section.
- On slide #3a mirror replica of the fluorescent pattern of the
figure "1 " from slide #1b_hybr was obtained. Thus, the Cy-3 labeledoligo # 003 hybridized to the slide #1b_hybr has been transferred to the surface of slide #3 (seeFig. 2 ). No transfer ofoligo # 003 from slide #1c_hybr to the slide #5 was observed. - Two-dimensional tissue sections are convenient objects to study distribution of molecules. Several sequential sections restore a 3D spatial location of molecules.
- Currently, transcripts in tissue sections are analyzed by in situ hybridization. Main restriction of this approach is the limited number of transcripts which it is possible to analyze simultaneously. The reason is that it is impossible to select considerable number of distinguishable labels for hybridization probes.
- However many molecular biology methods, for example, sequencing, cannot be performed directly in tissue sections. It would be advantageous to be able to transfer molecules from the tissue section to another surface or into solution, where appropriate methods of analysis could be performed.
- In this example it is described how transcripts in tissue sections may be analyzed by sequencing and ex situ hybridization.
- In the second generation sequencing (SGS) platforms sequencing is performed on the surface of the special flowcell for millions of templates in parallel. 2D flowcell surface is similar to the slide with tissue section. Sequencing cannot be performed directly in the tissue section. However using the method of the invention it is possible to transfer the transcripts (hybridization probes, primer extension products) from tissue section to the surface of sequencing flowcell preserving the distribution pattern.
-
- Hybridization probes would have the structure as shown on
Fig.3A . Middle parts of probes are for hybridization to transcripts in tissue section. Flanking regions a and b are common for all probes and are required both for hybridization and sequencing on the SGS flowcell surface (Fig.3B ). - Hybridization probes may be selected to target from single to thousands of transcripts. They may be synthesized artificially or prepared from a sequencing library.
- To prevent unspecific hybridization of common parts of the hybridization probes in tissue section it is possible to reversibly block them with complementary oligonucleotides. These oligonucleotides should be removed before transfer of hybridization probes to the SGS flowcell surface.
- Tissue section slide and SGS surface would be brought into tight contact, possibly with a net in between (see
Fig.4 ). The distance between surfaces (or the mesh size if a net is used) should be smaller than acceptable blurring of the distribution pattern. A net would also prevent direct contact of the tissue section and SGS surface. - Surfaces assembly would be done at room or lower temperature, so that the hybridization probes do not go off the surface. Detaching probes from the tissue section and attaching to the SGS surface would be regulated by the temperature. First, the temperature of the sandwich would be raised up to denaturize the hybridization probes. Then the temperature would be decreased to allow the common regions of hybridization probes anneal to the oligos immobilized on the SGS surface. In these conditions hybridization probes may hybridize back to the transcripts in tissue sections. However transcripts in the tissue section are few in comparison to oligos on the target surface, so probability to hybridize to the target surface is much higher than back to the tissue section.
- The time of denaturation would be selected to allow enough probes to denature and move into solution between the surfaces. The time of hybridization would be adjusted so that enough but not too many probes are transferred to provide a necessary density of sequencing templates and so that probes do not diffuse too far away.
- Before separating the surfaces, the temperature would be decreased close to 0°C. At low temperature hybridization speed becomes low, which prevents attaching of probes to the wrong places on SGS surface when sandwich is disturbed. Washing of the unhybridized probes from the SGS flowcell surface would be also performed at low temperature.
- Amplification of the transferred probes on the SGS flowcell surface and further sequencing would be performed according to the known sequencing procedures.
- SGS would determine two parameters for each probe: (i) its partial or complete nucleotide sequence and (ii) position on the slide surface. Nucleotide sequence will identify which particular transcript was a target for a probe. Position of a probe on a flowcell will be set into correspondence with the position on the tissue section.
- An alternative to SGS analysis as shown in example 2 is described.
- The procedure looks the same as described in example 2, with the difference in sequencing approach: molecules transferred from the tissue section are sequenced directly by single-molecule sequencing approach, where transferred molecules are sequenced directly on the target surface with capturing oligonucleotides initializing the primer extension. Since no amplification on the target surface is required, only one type of oligonucleotides can be present on the sequencing surface for capturing sequencing templates by hybridization. The hybridization probes may have a structure as shown in
Fig.8 . - This approach may be realized using single-molecule sequencing approach like for example that of Helicos. Single molecules sequencing allows for a higher density of sequencing templates.
- A further alternative to SGS analysis as shown in example 2 is described.
- The procedure looks the same as described in Application Example 2 till amplification of the transferred nucleic acid molecules on the target surface and removing of one strand. Then instead of sequencing, target surface is used for hybridisation with probes of interest. So, this is basically in situ hybridization but with targets transferred to another surface and amplified.
- In situ amplification results in ∼1000 copies of transferred molecule. This allows increasing hybridization signal and thus sensitivity of transcripts analysis.
- Another advantage of this approach is that it makes possible to use same replica for several hybridizations with different probes without increase of background. Target molecules are covalently attached to the surface, so it is possible to use stringent conditions to wash off probes from previous hybridization. This increases the throughput of analysis in comparison to in situ hybridization.
- The general scheme of the method is shown in
Fig.10 . This method allows to transfer transcripts (or corresponding to transcripts hybridization probes, primer extension products) from tissue section into solution preserving information about the distribution pattern. Molecules in the solution may be further processed according to standard sequencing protocols for sample preparation. Loading of sequencing flowcell would be performed as for standard sequencing library, so loading density will be even over the flowcell surface and adjustable. Having sequencing templates in the solution would also allow to use any SGS platform and thus be independent from the SGS surface. -
- Hybridization probes would have the structure as shown on
figure 9A . Middle parts of probes are for hybridization to transcripts in tissue section. Flanking regions are common for all probes and are required for hybridization to the coding surface (hybr. region) and sequencing on the SGS flowcell surface (seq. region 1). - To prevent unspecific hybridization of common parts of the hybridization probes in tissue section it is possible to reversibly block them with complementary oligonucleotides. These oligonucleotides should be removed before transfer of hybridization probes to the coding surface.
- Coding surface is covered with covalently attached coding oligonucleotides. Structure of coding oligonucleotides is shown on
Fig.9B . The 3' part, which is complementary to the hybridization region of the hybridization probes, is followed by code region. 5' part is required for further sequencing on the SGS flowcell (seq. region 2). Coding oligo may be detached from the surface using a cleavage site. Cleavage site may be organised for example by a chemically, thermally or enzymatically destroyable nucleotide. - Coding surface consists of coding regions, in each region coding oligos have a different code part. The more precise localisation of transcripts is required, the smaller coding regions should be used. The more coding regions should be on the surface - the longer code region is required to have a unique code in each region.
- Hybridized probes would be transferred to a coding surface as described in the example 2. Attachment to the coding surface would be realized by hybridisation of the hybridization region of the hybridization probes to the complementary 3' part of the oligos on the coding surface (
Fig. 9B ). The result of the transfer would be a coding surface with hybridization probes attached to it in a mirror-distribution relative to the distribution of corresponding transcripts in tissues section. - Transferred hybridization probes would be coded using primer extension reaction (
Fig. 9C ): depending on the coding region, hybridization probe will be extended with a certain code sequence. Primer extension mix would contain nucleotides and polymerase in an appropriate buffer. Mix would be pipetted over the surface using for example HybriWell chambers from Grace Biolabs. It is important that during primer extension reaction, hybridization probes do not go off their locations. Extension should therefore be performed at temperatures below annealing temperature of hybridization region. - The result of the extension would be double-stranded molecules, in which both strands have flanking regions required for sequencing and code regions, required for revealing molecules position (
Fig. 9C ). Coded molecules can be removed from the slide and combined in the solution. This may be performed in two ways. -
Variant 1. Coding surface would be rinsed in high-temperature (∼95°C) solution. At high temperature, duplexes will be denatured and non-covalently attached strands will go into solution. Also high temperature would inactivate the enzyme used for primer extension, so that no primer extension would be possible in the solution (which may cause chimeric molecules formation). Single-stranded sequencing templates have common flanking regions required for SGS and may be further amplified or used directly for clonal amplification. -
Variant 2. Duplexes would be removed from the coding surface after destroying of the cleavable group. Together with duplexes, non-extended coding oligos will also be removed from the coding surface, and may cause extension in solution, which may lead to wrong coding and formation of chimeric molecules. It is therefore necessary to pay attention that polymerase present in primer extention mix is washed away from the surface or inactivated prior to combining the duplexes in solution. Double-stranded sequencing templates (Fig. 9D ) may be further amplified or used directly for clonal amplification. - Further stages - amplification of the molecules, clonal amplification and sequencing would be performed according to the known SGS procedures (SOLiD platform from ABI; GA and HiSeq from Illumina).
- SGS would determine two sequences for each sequencing template: (i) partial or complete transcript-specific sequence and (ii) sequence of the code. Code sequence will be set into correspondence with the distribution scheme of position coding primers on the tissue section slide, and reveal the initial position of the transcript in the tissue section.
- An already sequenced SOLiD flowcell is used as the coding surface. Clonally amplified sequencing templates are attached to the beads. After sequencing, position of each bead and sequence of molecules attached to it are known. Thus, sequences may serve as codes for hybridization probes transferred from tissue section slide (
Fig.12 ). - Hybridization probes would have the structure as shown on
Fig.11 . Middle parts of probes are for hybridization to transcripts in tissue section. Flanking regions are common for all probes and are required for hybridization to the coding surface (hybridization region) and sequencing on the Illumina platform (illumination region 1). Hybridization region may hybridize to the common 3' region (P2) of SOLiD sequencing templates. - To prevent unspecific hybridization of common parts of the hybridization probes in tissue section it is possible to reversibly block them with complementary oligonucleotides. These oligonucleotides should be removed before transfer of hybridization probes to the coding surface.
- Coding surface is a sequenced SOLiD flowcell: glass slide covered with beads. Each bead is a different code region. Unique middle parts of sequencing templates serve as codes (
Fig. 11 B) . - Hybridized probes would be transferred to the coding surface as described in the example 2. Attachment to the sequencing templates would be realized by hybridization of the hybridization region of the hybridization probes to the complementary P2 regions (
Fig. 11 C) . The result of the transfer would be beads with hybridization probes attached to them. - Transferred hybridization probes would be coded using primer extension reaction (
Fig. 11 D) : depending on the bead to which it is attached, hybridization probe will be extended with a certain code sequence. Primer extension mix would contain nucleotides and polymerase in an appropriate buffer. Mix would be pipetted over the surface using for example HybriWell chambers from Grace Biolabs. It is important that during primer extension reaction, hybridization probes do not go off their locations. Extension should therefore be performed at temperatures below annealing temperature of hybridization region. Sequencing templates would not be extended because in the course of the SOLiD sequencing protocol they are 3' end blocked. - The result of the extension would be a hybridization probe to which the sequence of a SOLiD sequencing template is added, and which has a P1 sequence on 3'end (
Fig. 11E ). Coded molecules may be washed off the beads in denaturizing conditions and combined in solution. Single stranded coded molecules would be amplified to introduceillumination region 2 next to P1 part of the molecule. - Result of amplification would be double-stranded molecules flanked with Illumina-platform
specific illumination regions 1 and 2 (Fig.11F ), which may be further amplified or used directly for clonal amplification and sequencing on the Illumina platform. - Illumina sequencing would determine two sequences for each sequencing template: (i) partial or complete transcript-specific sequence and (ii) sequence of the code. Code sequences will reveal the position of corresponding beads on the SOLiD flowcell and thus the position of original transcripts in the tissue section.
- In the previous examples situations were described where the aim was to reveal position of the nucleic acid molecules distributed within tissue section.
- For analysis of a panel of samples with 2D distributed nucleic acid molecules (e.g. cell arrays, tissue arrays) it may be necessary to reveal from which sample nucleic acid molecules originate. Procedures described in examples 2-5, work for these applications, too. If coding is used to mark nucleic acid molecules from a single sample, size of coding regions on the coding surface may be comparable to the size of a sample.
- Replication method using holding nucleic acid molecules on the target surface by hybridization is highly selective. From a mix of nucleic acid molecules transferred from a sample with 2D distributed nucleic acid molecules to the target surface, only those will be replicated, which have a sequence complementary to the capturing oligonucleotides.
- Selectivity may be used for example for selection of full-length oligonucleotides after on-surface synthesis. Oligonucleotides synthesis is performed from 3' to 5' end. For selection of full-length oligos it is possible to use 5' sequences. In the
Fig.13A all synthesized oligonucleotides should have the same 5' region. Oligonucleotides complementary to this region are attached to the target surface. During replication of synthesized oligos to the target surface, only full length oligonucleotides get captured. - To create an array of full-length oligonucleotides another approach may be used, involving a coding surface (
Fig.13B ). Here oligonucleotides synthesized in each array feature have a different 5' region. Capturing oligonucleotides complementary to these 5' regions are synthesized on another array. Features are located in such a way that complementary sequences during replication are opposite to each other. -
Claims (18)
- Using of hybridization of nucleic acids for creating replicas of nucleic acids molecules or molecular complexes containing nucleic acid molecules located either on a surface or within a layer, wherein said creating replicas is obtaining on a target surface the relative distribution of nucleic acid molecules or molecular complexes containing nucleic acid molecules resembling the original distribution.
- Replication method, comprising the following steps:a) providing sample with nucleic acid molecules located either on a surface or within a layer;b) providing target surface with nucleic acid molecules, capable to hybridization-based binding to nucleic acid molecules from (a);c) (option 1) if nucleic acid molecules are not attached to the sample, providing conditions to minimize shift of molecules from the original positions;d) (option 2) if nucleic acid molecules are attached to the sample, providing conditions for gradual releasing of nucleic acid molecules;e) assembling sample with nucleic acid molecules from (a) against the target surface from (b) with solution in between, such that nucleic acid molecules from the sample can reach target surface by diffusion through solution;f) (option 3) if nucleic acid molecules are attached to the sample, providing conditions for releasing nucleic acid molecules from the original positions in the sample,g) providing conditions for diffusion of nucleic acid molecules from the sample to the target surface and hybridization-based binding of nucleic acid molecules from the sample to the nucleic acid molecules on the target surface;h) (optional) providing conditions for slowing down the formation of new hybrids of nucleic acid molecules;i) disassembling the sample (a) and target surface (b).
- Replication method according to claim 2, wherein in step h) slowing down formation of new hybrids of nucleic acid molecules is done by decreasing the temperature of the assembly.
- Replication method according to claim 2, wherein said nucleic acid molecules located on a surface are distributed on a nucleic acid array or protein array, and wherein said nucleic acid molecules distributed within a layer are distributed in a gel layer, in tissue section, in cell or tissue array or in block of tissue.
- Replication method according to claim 2 wherein in step g) said hybridization-based binding occurs through adapter oligonucleotides which are complementary both to the nucleic acid molecules from the sample and to the nucleic acid molecules on the target surface.
- Replication method according to claim 2, wherein in step c) said conditions to minimize shift of molecules from the original positions is decrease of temperature.
- Replication method according to claim 2, wherein in step d) nucleic acid molecules in the sample are held on the original positions by chemical- or enzyme- sensitive binding and said gradual releasing of nucleic acid molecules from the sample is provided by the cleavage agent which acts slow enough to ignore those molecules which change the position before assembling sample against the target surface in step e).
- Replication method according to claim 7 wherein said conditions for gradual releasing of nucleic acid molecules from the sample by the cleavage agent are provided by decreasing concentration of the said agent or by providing reaction conditions decreasing the activity of the said agent.
- Replication method according to claim 2, wherein in step f) said condition for releasing the nucleic acid molecules from the original positions in the sample is increasing of the temperature.
- Replication method according to claim 9, wherein the nucleic acid molecules are held on the original positions in the sample by temperature-sensitive binding or the solution in step e) comprises a thermoactivated cleavage agent.
- Replication method according to claim 10 wherein said temperature sensitive binding is by hybridization or through thermolabile covalent bonds, abasic site or formaldehyde linkages, and wherein said thermoactivated cleavage agent is an enzyme or chemical reagent.
- Replication method according to claim 2, wherein in step f) said condition for releasing the nucleic acid molecules from the original positions in the sample is changing the solution between the sample and the target surface.
- Replication method according to claims 12 wherein the nucleic acid molecules are held on the original positions in the sample by hybridization and said new solution destabilizes hybridization by changing pH or ionic strength of the solution or by decreasing the melting temperature of the duplex like formamide, or the nucleic acid molecules are held on the original positions in the sample by chemical- or enzyme- sensitive binding and said new solution contains a cleavage agent, and wherein either the sample or the target surface or both are permeable for the said solution and during changing of the solution the assembly remains intact.
- Replication method according to claim 2, wherein in step f) said condition for releasing the nucleic acid molecules from the original positions in the sample is light.
- Replication method according to claim 14 wherein the nucleic acid molecules are held on the original positions in the sample by photocleavable binding and wherein either the sample or the target surface are transparent for the light with required wavelength.
- Performing enzymatic reactions with replicas on the target surface according to claim 1, wherein said enzymatic reactions include primer extension, ligation, rolling circle amplification, in situ PCR amplification, bridge PCR amplification, sequencing, restriction.
- Replication method according to claims 2-16 where nucleic acid molecules in the sample or nucleic acid molecules on the target surface contain known sequences, which (optionally) get inserted in the nucleic acid molecules from the target surface or nucleic acid molecules from the sample by primer extension or ligation reactions and said known sequences are further used for analysis of replicas, wherein said analysis may be performed on the target surface or in solution.
- Replication method according to claim 17 where the said known sequences serve to distinguish the samples, target surfaces, replication experiments, wherein said known sequences are different between the samples, target surfaces, replication experiments or to determine the position of nucleic acid molecules on the target surface or in the sample and wherein said known sequences are different in different regions of the sample or of the target.
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12163055.2A EP2647426A1 (en) | 2012-04-03 | 2012-04-03 | Replication of distributed nucleic acid molecules with preservation of their relative distribution through hybridization-based binding |
EP13713907.7A EP2833997A1 (en) | 2012-04-03 | 2013-04-03 | Hybridization-based replication of nucleic acid molecules |
US14/389,907 US20150072867A1 (en) | 2012-04-03 | 2013-04-03 | Analysis of nucleic acid molecules distributed on a surface or within a layer by sequencing with position identification |
PCT/EP2013/057052 WO2013150082A1 (en) | 2012-04-03 | 2013-04-03 | Hybridization-based replication of nucleic acid molecules |
CA2868689A CA2868689A1 (en) | 2012-04-03 | 2013-04-03 | Hybridization-based replication of nucleic acid molecules |
US14/388,669 US20150141269A1 (en) | 2012-04-03 | 2013-04-03 | Hybridization-based replication of nucleic acid molecules |
CA2868691A CA2868691A1 (en) | 2012-04-03 | 2013-04-03 | Analysis of nucleic acid molecules distributed on a surface or within a layer by sequencing with position identification |
PCT/EP2013/057053 WO2013150083A1 (en) | 2012-04-03 | 2013-04-03 | Analysis of nucleic acid molecules distributed on a surface or within a layer by sequencing with position identification |
EP13713908.5A EP2833998A1 (en) | 2012-04-03 | 2013-04-03 | Analysis of nucleic acid molecules distributed on a surface or within a layer by sequencing with position identification |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12163055.2A EP2647426A1 (en) | 2012-04-03 | 2012-04-03 | Replication of distributed nucleic acid molecules with preservation of their relative distribution through hybridization-based binding |
Publications (1)
Publication Number | Publication Date |
---|---|
EP2647426A1 true EP2647426A1 (en) | 2013-10-09 |
Family
ID=45937019
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP12163055.2A Withdrawn EP2647426A1 (en) | 2012-04-03 | 2012-04-03 | Replication of distributed nucleic acid molecules with preservation of their relative distribution through hybridization-based binding |
EP13713908.5A Withdrawn EP2833998A1 (en) | 2012-04-03 | 2013-04-03 | Analysis of nucleic acid molecules distributed on a surface or within a layer by sequencing with position identification |
EP13713907.7A Withdrawn EP2833997A1 (en) | 2012-04-03 | 2013-04-03 | Hybridization-based replication of nucleic acid molecules |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP13713908.5A Withdrawn EP2833998A1 (en) | 2012-04-03 | 2013-04-03 | Analysis of nucleic acid molecules distributed on a surface or within a layer by sequencing with position identification |
EP13713907.7A Withdrawn EP2833997A1 (en) | 2012-04-03 | 2013-04-03 | Hybridization-based replication of nucleic acid molecules |
Country Status (4)
Country | Link |
---|---|
US (2) | US20150072867A1 (en) |
EP (3) | EP2647426A1 (en) |
CA (2) | CA2868689A1 (en) |
WO (2) | WO2013150083A1 (en) |
Families Citing this family (136)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8835358B2 (en) | 2009-12-15 | 2014-09-16 | Cellular Research, Inc. | Digital counting of individual molecules by stochastic attachment of diverse labels |
US20190300945A1 (en) | 2010-04-05 | 2019-10-03 | Prognosys Biosciences, Inc. | Spatially Encoded Biological Assays |
US10787701B2 (en) | 2010-04-05 | 2020-09-29 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
AU2011237729B2 (en) | 2010-04-05 | 2014-04-03 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
WO2012135805A2 (en) | 2011-03-31 | 2012-10-04 | modeRNA Therapeutics | Delivery and formulation of engineered nucleic acids |
GB201106254D0 (en) | 2011-04-13 | 2011-05-25 | Frisen Jonas | Method and product |
EP3321378B1 (en) | 2012-02-27 | 2021-11-10 | Becton, Dickinson and Company | Compositions for molecular counting |
US10273541B2 (en) | 2012-08-14 | 2019-04-30 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US10752949B2 (en) | 2012-08-14 | 2020-08-25 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US9701998B2 (en) | 2012-12-14 | 2017-07-11 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US10400280B2 (en) | 2012-08-14 | 2019-09-03 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US10221442B2 (en) | 2012-08-14 | 2019-03-05 | 10X Genomics, Inc. | Compositions and methods for sample processing |
CN104769127A (en) | 2012-08-14 | 2015-07-08 | 10X基因组学有限公司 | Microcapsule compositions and methods |
US11591637B2 (en) | 2012-08-14 | 2023-02-28 | 10X Genomics, Inc. | Compositions and methods for sample processing |
US9951386B2 (en) | 2014-06-26 | 2018-04-24 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US10323279B2 (en) | 2012-08-14 | 2019-06-18 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
CA2886974C (en) | 2012-10-17 | 2021-06-29 | Spatial Transcriptomics Ab | Methods and product for optimising localised or spatial detection of gene expression in a tissue sample |
AU2013359165B2 (en) | 2012-12-14 | 2019-09-12 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US10533221B2 (en) | 2012-12-14 | 2020-01-14 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
AU2014214682B2 (en) | 2013-02-08 | 2018-07-26 | 10X Genomics, Inc. | Polynucleotide barcode generation |
US10590161B2 (en) | 2013-03-15 | 2020-03-17 | Modernatx, Inc. | Ion exchange purification of mRNA |
US10138507B2 (en) | 2013-03-15 | 2018-11-27 | Modernatx, Inc. | Manufacturing methods for production of RNA transcripts |
EP4279610A3 (en) | 2013-03-15 | 2024-01-03 | ModernaTX, Inc. | Ribonucleic acid purification |
EP2971165A4 (en) | 2013-03-15 | 2016-11-23 | Moderna Therapeutics Inc | ELIMINATING DNA FRAGMENTS IN METHODS OF PRODUCING MRNA |
CN104769110A (en) * | 2013-05-22 | 2015-07-08 | 奥林巴斯株式会社 | Nucleic acid analysis kit and nucleic acid analysis method |
CN111500680B (en) | 2013-06-25 | 2024-04-16 | 普罗格诺西斯生物科学公司 | Method and system for detecting spatial distribution of biological targets in a sample |
DK3019619T3 (en) | 2013-07-11 | 2021-10-11 | Modernatx Inc | COMPOSITIONS INCLUDING SYNTHETIC POLYNUCLEOTIDES CODING CRISPR-RELATED PROTEINS, SYNTHETIC SGRNAs, AND USES OF USE |
DK3039158T3 (en) | 2013-08-28 | 2019-03-04 | Becton Dickinson Co | MASSIVE PARALLEL SINGLE CELL CELL ANALYSIS |
US9834814B2 (en) | 2013-11-22 | 2017-12-05 | Agilent Technologies, Inc. | Spatial molecular barcoding of in situ nucleic acids |
CN107002117B (en) | 2013-12-05 | 2021-12-10 | 生捷科技控股公司 | Nucleic acid sequencing method |
US10391467B2 (en) | 2013-12-05 | 2019-08-27 | Centrillion Technology Holdings Corporation | Fabrication of patterned arrays |
CN105940024B (en) | 2013-12-05 | 2019-03-15 | 生捷科技控股公司 | The surface of modification |
EP2883963A1 (en) * | 2013-12-16 | 2015-06-17 | Alacris Theranostics GmbH | Method for generating of oligonucleotide arrays using in situ block synthesis approach |
US20150247844A1 (en) * | 2014-02-28 | 2015-09-03 | Stanislav L. Karsten | Method for Obtaining Cell and Tissue Specific Biomolecules |
US11060139B2 (en) | 2014-03-28 | 2021-07-13 | Centrillion Technology Holdings Corporation | Methods for sequencing nucleic acids |
WO2015157567A1 (en) | 2014-04-10 | 2015-10-15 | 10X Genomics, Inc. | Fluidic devices, systems, and methods for encapsulating and partitioning reagents, and applications of same |
US10286086B2 (en) | 2014-06-19 | 2019-05-14 | Modernatx, Inc. | Alternative nucleic acid molecules and uses thereof |
JP6838969B2 (en) | 2014-06-26 | 2021-03-03 | 10エックス ジェノミクス, インコーポレイテッド | Method for Analyzing Nucleic Acids Derived from Individual Cells or Cell Populations |
WO2015200869A1 (en) | 2014-06-26 | 2015-12-30 | 10X Genomics, Inc. | Analysis of nucleic acid sequences |
WO2016011222A2 (en) | 2014-07-16 | 2016-01-21 | Moderna Therapeutics, Inc. | Circular polynucleotides |
US20160122817A1 (en) | 2014-10-29 | 2016-05-05 | 10X Genomics, Inc. | Methods and compositions for targeted nucleic acid sequencing |
US9975122B2 (en) | 2014-11-05 | 2018-05-22 | 10X Genomics, Inc. | Instrument systems for integrated sample processing |
CA2972969A1 (en) | 2015-01-12 | 2016-07-21 | 10X Genomics, Inc. | Processes and systems for preparing nucleic acid sequencing libraries and libraries prepared using same |
MX2017010857A (en) | 2015-02-24 | 2017-12-11 | 10X Genomics Inc | Methods for targeted nucleic acid sequence coverage. |
WO2016137973A1 (en) | 2015-02-24 | 2016-09-01 | 10X Genomics Inc | Partition processing methods and systems |
EP3262192B1 (en) | 2015-02-27 | 2020-09-16 | Becton, Dickinson and Company | Spatially addressable molecular barcoding |
EP3277843A2 (en) | 2015-03-30 | 2018-02-07 | Cellular Research, Inc. | Methods and compositions for combinatorial barcoding |
CN107532207B (en) | 2015-04-10 | 2021-05-07 | 空间转录公司 | Spatially differentiated, multiplexed nucleic acid analysis of biological samples |
EP3286326B1 (en) | 2015-04-23 | 2025-01-22 | Becton, Dickinson and Company | Method for whole transcriptome amplification |
WO2016201111A1 (en) * | 2015-06-09 | 2016-12-15 | Centrillion Technology Holdings Corporation | Methods for sequencing nucleic acids |
DK3329012T3 (en) * | 2015-07-27 | 2021-10-11 | Illumina Inc | Spatial mapping of nucleic acid sequence information |
ES2745694T3 (en) | 2015-09-11 | 2020-03-03 | Cellular Res Inc | Methods and compositions for nucleic acid library normalization |
US11434486B2 (en) | 2015-09-17 | 2022-09-06 | Modernatx, Inc. | Polynucleotides containing a morpholino linker |
PT3350333T (en) | 2015-09-17 | 2022-03-02 | Modernatx Inc | Polynucleotides containing a stabilizing tail region |
CN115369161A (en) | 2015-12-04 | 2022-11-22 | 10X 基因组学有限公司 | Methods and compositions for nucleic acid analysis |
WO2017197338A1 (en) | 2016-05-13 | 2017-11-16 | 10X Genomics, Inc. | Microfluidic systems and methods of use |
US10301677B2 (en) | 2016-05-25 | 2019-05-28 | Cellular Research, Inc. | Normalization of nucleic acid libraries |
US10640763B2 (en) | 2016-05-31 | 2020-05-05 | Cellular Research, Inc. | Molecular indexing of internal sequences |
US10202641B2 (en) | 2016-05-31 | 2019-02-12 | Cellular Research, Inc. | Error correction in amplification of samples |
JP7091348B2 (en) | 2016-09-26 | 2022-06-27 | ベクトン・ディキンソン・アンド・カンパニー | Measurement of protein expression using reagents with barcoded oligonucleotide sequences |
US10011872B1 (en) | 2016-12-22 | 2018-07-03 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US10815525B2 (en) | 2016-12-22 | 2020-10-27 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US10550429B2 (en) | 2016-12-22 | 2020-02-04 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
CN110214186B (en) | 2017-01-30 | 2023-11-24 | 10X基因组学有限公司 | Methods and systems for droplet-based single cell barcoding |
US12264411B2 (en) | 2017-01-30 | 2025-04-01 | 10X Genomics, Inc. | Methods and systems for analysis |
EP3577232A1 (en) | 2017-02-01 | 2019-12-11 | Cellular Research, Inc. | Selective amplification using blocking oligonucleotides |
US20180340169A1 (en) | 2017-05-26 | 2018-11-29 | 10X Genomics, Inc. | Single cell analysis of transposase accessible chromatin |
CN116064732A (en) | 2017-05-26 | 2023-05-05 | 10X基因组学有限公司 | Single-cell analysis of transposase-accessible chromatin |
CA3059559A1 (en) | 2017-06-05 | 2018-12-13 | Becton, Dickinson And Company | Sample indexing for single cells |
WO2019099751A1 (en) | 2017-11-15 | 2019-05-23 | 10X Genomics, Inc. | Functionalized gel beads |
US10829815B2 (en) | 2017-11-17 | 2020-11-10 | 10X Genomics, Inc. | Methods and systems for associating physical and genetic properties of biological particles |
WO2019195166A1 (en) | 2018-04-06 | 2019-10-10 | 10X Genomics, Inc. | Systems and methods for quality control in single cell processing |
EP4545647A2 (en) | 2018-05-03 | 2025-04-30 | Becton, Dickinson and Company | Molecular barcoding on opposite transcript ends |
EP4234717A3 (en) | 2018-05-03 | 2023-11-01 | Becton, Dickinson and Company | High throughput multiomics sample analysis |
US11519033B2 (en) | 2018-08-28 | 2022-12-06 | 10X Genomics, Inc. | Method for transposase-mediated spatial tagging and analyzing genomic DNA in a biological sample |
CN112805389B (en) | 2018-10-01 | 2024-08-06 | 贝克顿迪金森公司 | Determine 5' transcript sequence |
JP7618548B2 (en) | 2018-11-08 | 2025-01-21 | ベクトン・ディキンソン・アンド・カンパニー | Whole-transcriptome analysis of single cells using random priming |
EP3894552A1 (en) | 2018-12-13 | 2021-10-20 | Becton, Dickinson and Company | Selective extension in single cell whole transcriptome analysis |
US11926867B2 (en) | 2019-01-06 | 2024-03-12 | 10X Genomics, Inc. | Generating capture probes for spatial analysis |
US11649485B2 (en) | 2019-01-06 | 2023-05-16 | 10X Genomics, Inc. | Generating capture probes for spatial analysis |
US11661631B2 (en) | 2019-01-23 | 2023-05-30 | Becton, Dickinson And Company | Oligonucleotides associated with antibodies |
CN113454234B (en) * | 2019-02-14 | 2025-03-18 | 贝克顿迪金森公司 | Heterozygote targeted and whole transcriptome amplification |
EP3976820A1 (en) | 2019-05-30 | 2022-04-06 | 10X Genomics, Inc. | Methods of detecting spatial heterogeneity of a biological sample |
CN114051534B (en) | 2019-07-22 | 2025-02-21 | 贝克顿迪金森公司 | Single-cell chromatin immunoprecipitation sequencing assay |
WO2021092433A2 (en) | 2019-11-08 | 2021-05-14 | 10X Genomics, Inc. | Enhancing specificity of analyte binding |
US11773436B2 (en) | 2019-11-08 | 2023-10-03 | Becton, Dickinson And Company | Using random priming to obtain full-length V(D)J information for immune repertoire sequencing |
EP4055185A1 (en) | 2019-11-08 | 2022-09-14 | 10X Genomics, Inc. | Spatially-tagged analyte capture agents for analyte multiplexing |
SG11202106899SA (en) | 2019-12-23 | 2021-09-29 | 10X Genomics Inc | Methods for spatial analysis using rna-templated ligation |
CN115038794A (en) | 2019-12-23 | 2022-09-09 | 10X基因组学有限公司 | Compositions and methods for using fixed biological samples in partition-based assays |
CN115244184A (en) | 2020-01-13 | 2022-10-25 | 贝克顿迪金森公司 | Methods and compositions for quantification of protein and RNA |
US11702693B2 (en) | 2020-01-21 | 2023-07-18 | 10X Genomics, Inc. | Methods for printing cells and generating arrays of barcoded cells |
US11732299B2 (en) | 2020-01-21 | 2023-08-22 | 10X Genomics, Inc. | Spatial assays with perturbed cells |
EP4471155A3 (en) | 2020-01-29 | 2024-12-18 | Becton, Dickinson and Company | Barcoded wells for spatial mapping of single cells through sequencing |
US11821035B1 (en) | 2020-01-29 | 2023-11-21 | 10X Genomics, Inc. | Compositions and methods of making gene expression libraries |
US12076701B2 (en) | 2020-01-31 | 2024-09-03 | 10X Genomics, Inc. | Capturing oligonucleotides in spatial transcriptomics |
US11898205B2 (en) | 2020-02-03 | 2024-02-13 | 10X Genomics, Inc. | Increasing capture efficiency of spatial assays |
US12110541B2 (en) | 2020-02-03 | 2024-10-08 | 10X Genomics, Inc. | Methods for preparing high-resolution spatial arrays |
US11732300B2 (en) | 2020-02-05 | 2023-08-22 | 10X Genomics, Inc. | Increasing efficiency of spatial analysis in a biological sample |
US12129516B2 (en) | 2020-02-07 | 2024-10-29 | 10X Genomics, Inc. | Quantitative and automated permeabilization performance evaluation for spatial transcriptomics |
US11835462B2 (en) | 2020-02-11 | 2023-12-05 | 10X Genomics, Inc. | Methods and compositions for partitioning a biological sample |
US12281357B1 (en) | 2020-02-14 | 2025-04-22 | 10X Genomics, Inc. | In situ spatial barcoding |
US11891654B2 (en) | 2020-02-24 | 2024-02-06 | 10X Genomics, Inc. | Methods of making gene expression libraries |
CN115151810A (en) | 2020-02-25 | 2022-10-04 | 贝克顿迪金森公司 | Enables bispecific probes using single-cell samples as single-color compensation controls |
US11926863B1 (en) | 2020-02-27 | 2024-03-12 | 10X Genomics, Inc. | Solid state single cell method for analyzing fixed biological cells |
US11768175B1 (en) | 2020-03-04 | 2023-09-26 | 10X Genomics, Inc. | Electrophoretic methods for spatial analysis |
ES2965354T3 (en) | 2020-04-22 | 2024-04-12 | 10X Genomics Inc | Methods for spatial analysis using targeted RNA deletion |
EP4150118A1 (en) | 2020-05-14 | 2023-03-22 | Becton Dickinson and Company | Primers for immune repertoire profiling |
EP4153775B1 (en) | 2020-05-22 | 2024-07-24 | 10X Genomics, Inc. | Simultaneous spatio-temporal measurement of gene expression and cellular activity |
EP4153776B1 (en) | 2020-05-22 | 2025-03-05 | 10X Genomics, Inc. | Spatial analysis to detect sequence variants |
WO2021242834A1 (en) | 2020-05-26 | 2021-12-02 | 10X Genomics, Inc. | Method for resetting an array |
CN116249785A (en) | 2020-06-02 | 2023-06-09 | 10X基因组学有限公司 | Spatial Transcriptomics for Antigen-Receptors |
WO2021247543A2 (en) | 2020-06-02 | 2021-12-09 | 10X Genomics, Inc. | Nucleic acid library methods |
EP4158055B1 (en) | 2020-06-02 | 2024-03-27 | Becton, Dickinson and Company | Oligonucleotides and beads for 5 prime gene expression assay |
US12265079B1 (en) | 2020-06-02 | 2025-04-01 | 10X Genomics, Inc. | Systems and methods for detecting analytes from captured single biological particles |
US12031177B1 (en) | 2020-06-04 | 2024-07-09 | 10X Genomics, Inc. | Methods of enhancing spatial resolution of transcripts |
ES2981265T3 (en) | 2020-06-08 | 2024-10-08 | 10X Genomics Inc | Methods for determining a surgical margin and methods of using it |
EP4165207B1 (en) | 2020-06-10 | 2024-09-25 | 10X Genomics, Inc. | Methods for determining a location of an analyte in a biological sample |
EP4172362B1 (en) | 2020-06-25 | 2024-09-18 | 10X Genomics, Inc. | Spatial analysis of dna methylation |
US11981960B1 (en) | 2020-07-06 | 2024-05-14 | 10X Genomics, Inc. | Spatial analysis utilizing degradable hydrogels |
US12209280B1 (en) | 2020-07-06 | 2025-01-28 | 10X Genomics, Inc. | Methods of identifying abundance and location of an analyte in a biological sample using second strand synthesis |
US11761038B1 (en) | 2020-07-06 | 2023-09-19 | 10X Genomics, Inc. | Methods for identifying a location of an RNA in a biological sample |
US11932901B2 (en) | 2020-07-13 | 2024-03-19 | Becton, Dickinson And Company | Target enrichment using nucleic acid probes for scRNAseq |
US11981958B1 (en) | 2020-08-20 | 2024-05-14 | 10X Genomics, Inc. | Methods for spatial analysis using DNA capture |
CN116194590A (en) | 2020-09-18 | 2023-05-30 | 10X基因组学有限公司 | Sample processing apparatus and image registration method |
US11926822B1 (en) | 2020-09-23 | 2024-03-12 | 10X Genomics, Inc. | Three-dimensional spatial analysis |
US11827935B1 (en) | 2020-11-19 | 2023-11-28 | 10X Genomics, Inc. | Methods for spatial analysis using rolling circle amplification and detection probes |
CN116635533A (en) | 2020-11-20 | 2023-08-22 | 贝克顿迪金森公司 | Profiling of high and low expressed proteins |
EP4121555A1 (en) | 2020-12-21 | 2023-01-25 | 10X Genomics, Inc. | Methods, compositions, and systems for capturing probes and/or barcodes |
EP4294571B8 (en) | 2021-02-19 | 2024-07-10 | 10X Genomics, Inc. | Method of using a modular assay support device |
ES3008686T3 (en) | 2021-03-18 | 2025-03-24 | 10X Genomics Inc | Multiplex capture of gene and protein expression from a biological sample |
EP4305196B1 (en) | 2021-04-14 | 2025-04-02 | 10X Genomics, Inc. | Methods of measuring mislocalization of an analyte |
EP4347879B1 (en) | 2021-06-03 | 2025-02-19 | 10X Genomics, Inc. | Methods, compositions, kits, and systems for enhancing analyte capture for spatial analysis |
EP4196605B1 (en) | 2021-09-01 | 2024-12-04 | 10X Genomics, Inc. | Methods for blocking a capture probe on a spatial array |
EP4419707A1 (en) | 2021-11-10 | 2024-08-28 | 10X Genomics, Inc. | Methods, compositions, and kits for determining the location of an analyte in a biological sample |
WO2023102118A2 (en) | 2021-12-01 | 2023-06-08 | 10X Genomics, Inc. | Methods, compositions, and systems for improved in situ detection of analytes and spatial analysis |
EP4441711A1 (en) | 2021-12-20 | 2024-10-09 | 10X Genomics, Inc. | Self-test for pathology/histology slide imaging device |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5795714A (en) * | 1992-11-06 | 1998-08-18 | Trustees Of Boston University | Method for replicating an array of nucleic acid probes |
WO1999019341A1 (en) * | 1997-10-10 | 1999-04-22 | President & Fellows Of Harvard College | Replica amplification of nucleic acid arrays |
WO2004067759A2 (en) * | 2003-01-29 | 2004-08-12 | Cranfield University | Replication of nucleic acid arrays |
WO2008022332A2 (en) * | 2006-08-18 | 2008-02-21 | Board Of Regents, The University Of Texas System | System, method and kit for replicating a dna array |
WO2008027262A1 (en) * | 2006-08-28 | 2008-03-06 | Massachusetts Institute Of Technology | Liquid supramolecular nanostamping (lisuns) |
WO2009039202A1 (en) * | 2007-09-17 | 2009-03-26 | Twof, Inc. | Hydrogel labeled primer extension method for microarrays |
US7785790B1 (en) | 1997-10-10 | 2010-08-31 | President And Fellows Of Harvard College | Replica amplification of nucleic acid arrays |
WO2010100265A1 (en) * | 2009-03-06 | 2010-09-10 | Hahn-Schickard-Gesellschaft für angewandte Forschung e.V. | Device and method for producing a replicate or derivative from an array of molecules, and applications thereof |
US7862849B2 (en) | 2003-10-17 | 2011-01-04 | Massachusetts Institute Of Technology | Nanocontact printing |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993017126A1 (en) * | 1992-02-19 | 1993-09-02 | The Public Health Research Institute Of The City Of New York, Inc. | Novel oligonucleotide arrays and their use for sorting, isolating, sequencing, and manipulating nucleic acids |
US20030096239A1 (en) * | 2000-08-25 | 2003-05-22 | Kevin Gunderson | Probes and decoder oligonucleotides |
WO2004031366A2 (en) * | 2002-10-02 | 2004-04-15 | New Light Industries, Ltd | Manufacturing method and readout system for biopolymer arrays |
US20040185443A1 (en) * | 2003-03-18 | 2004-09-23 | Dahl Gary A. | Analyte-specific assays based on formation of a replicase substrate |
US20070099195A1 (en) * | 2005-11-02 | 2007-05-03 | Huang Xiaohua C | Methods and compositions for separating nucleic acids from a solid support |
US7291471B2 (en) * | 2005-11-21 | 2007-11-06 | Agilent Technologies, Inc. | Cleavable oligonucleotide arrays |
KR100829574B1 (en) * | 2006-01-03 | 2008-05-14 | 삼성전자주식회사 | Lab-on-a-chip comprising a microarray substrate, a method for analyzing biomolecules using the microarray substrate, and the microarray substrate |
WO2010088517A1 (en) * | 2009-01-30 | 2010-08-05 | The U.S.A., As Represented By The Secretary, Department Of Health And Human Services | Methods and systems for purifying transferring and/or manipulating nucleic acids |
WO2011068088A1 (en) * | 2009-12-04 | 2011-06-09 | 株式会社日立製作所 | GENE EXPRESSION ANALYSIS METHOD USING TWO DIMENSIONAL cDNA LIBRARY |
GB201106254D0 (en) * | 2011-04-13 | 2011-05-25 | Frisen Jonas | Method and product |
-
2012
- 2012-04-03 EP EP12163055.2A patent/EP2647426A1/en not_active Withdrawn
-
2013
- 2013-04-03 CA CA2868689A patent/CA2868689A1/en not_active Abandoned
- 2013-04-03 WO PCT/EP2013/057053 patent/WO2013150083A1/en active Application Filing
- 2013-04-03 US US14/389,907 patent/US20150072867A1/en not_active Abandoned
- 2013-04-03 EP EP13713908.5A patent/EP2833998A1/en not_active Withdrawn
- 2013-04-03 EP EP13713907.7A patent/EP2833997A1/en not_active Withdrawn
- 2013-04-03 CA CA2868691A patent/CA2868691A1/en not_active Abandoned
- 2013-04-03 US US14/388,669 patent/US20150141269A1/en not_active Abandoned
- 2013-04-03 WO PCT/EP2013/057052 patent/WO2013150082A1/en active Application Filing
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5795714A (en) * | 1992-11-06 | 1998-08-18 | Trustees Of Boston University | Method for replicating an array of nucleic acid probes |
WO1999019341A1 (en) * | 1997-10-10 | 1999-04-22 | President & Fellows Of Harvard College | Replica amplification of nucleic acid arrays |
US7785790B1 (en) | 1997-10-10 | 2010-08-31 | President And Fellows Of Harvard College | Replica amplification of nucleic acid arrays |
WO2004067759A2 (en) * | 2003-01-29 | 2004-08-12 | Cranfield University | Replication of nucleic acid arrays |
US7862849B2 (en) | 2003-10-17 | 2011-01-04 | Massachusetts Institute Of Technology | Nanocontact printing |
WO2008022332A2 (en) * | 2006-08-18 | 2008-02-21 | Board Of Regents, The University Of Texas System | System, method and kit for replicating a dna array |
WO2008027262A1 (en) * | 2006-08-28 | 2008-03-06 | Massachusetts Institute Of Technology | Liquid supramolecular nanostamping (lisuns) |
WO2009039202A1 (en) * | 2007-09-17 | 2009-03-26 | Twof, Inc. | Hydrogel labeled primer extension method for microarrays |
WO2010100265A1 (en) * | 2009-03-06 | 2010-09-10 | Hahn-Schickard-Gesellschaft für angewandte Forschung e.V. | Device and method for producing a replicate or derivative from an array of molecules, and applications thereof |
Also Published As
Publication number | Publication date |
---|---|
WO2013150082A1 (en) | 2013-10-10 |
CA2868689A1 (en) | 2013-10-10 |
EP2833997A1 (en) | 2015-02-11 |
EP2833998A1 (en) | 2015-02-11 |
CA2868691A1 (en) | 2013-10-10 |
WO2013150083A1 (en) | 2013-10-10 |
US20150141269A1 (en) | 2015-05-21 |
US20150072867A1 (en) | 2015-03-12 |
WO2013150082A8 (en) | 2014-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2647426A1 (en) | Replication of distributed nucleic acid molecules with preservation of their relative distribution through hybridization-based binding | |
JP6875998B2 (en) | Spatial mapping of molecular profiles of biological tissue samples | |
CA2810931C (en) | Direct capture, amplification and sequencing of target dna using immobilized primers | |
JP5951755B2 (en) | Improved quantitative nuclease protection assay (qNPA) and quantitative nuclease protection sequencing (qNPS) methods | |
CN103781918B (en) | The method and product detected for the part of tissue samples amplifying nucleic acid or space | |
US20070141604A1 (en) | Method of target enrichment | |
US20080274904A1 (en) | Method of target enrichment | |
WO2016189331A1 (en) | Surface-based tagmentation | |
US20130344540A1 (en) | Methods for minimizing sequence specific bias | |
JP6716465B2 (en) | Sequencing of accumulated single cells | |
DK2456892T3 (en) | Procedure for sequencing of a polynukleotidskabelon | |
US12060554B2 (en) | Method for selecting and amplifying polynucleotides | |
US20070231802A1 (en) | Method for evaluating integrity of a genomic sample | |
KR20250065218A (en) | Highly sensitive methods for accurate parallel quantification of nucleic acids | |
Ma | Multiplex Gene Synthesis and Error Correction from Microchips Oligonucleotides and | |
EP1113080A2 (en) | Personal gene library |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20140410 |